JPWO2019191229A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019191229A5 JPWO2019191229A5 JP2020551538A JP2020551538A JPWO2019191229A5 JP WO2019191229 A5 JPWO2019191229 A5 JP WO2019191229A5 JP 2020551538 A JP2020551538 A JP 2020551538A JP 2020551538 A JP2020551538 A JP 2020551538A JP WO2019191229 A5 JPWO2019191229 A5 JP WO2019191229A5
- Authority
- JP
- Japan
- Prior art keywords
- triazine
- phenol
- methyl
- amino
- pyrazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 {[(pyridine-2-yl) Methyl] Amino} Methyl Chemical group 0.000 claims description 590
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 166
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 123
- 125000000217 alkyl group Chemical group 0.000 claims description 44
- 150000001875 compounds Chemical class 0.000 claims description 38
- 125000003545 alkoxy group Chemical group 0.000 claims description 24
- 125000001424 substituent group Chemical group 0.000 claims description 11
- 125000002619 bicyclic group Chemical group 0.000 claims description 7
- 125000002950 monocyclic group Chemical group 0.000 claims description 7
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 193
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 55
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 51
- JELQZSVKOONUKD-UHFFFAOYSA-N phenol dihydrochloride Chemical compound Cl.Cl.OC1=CC=CC=C1.OC1=CC=CC=C1 JELQZSVKOONUKD-UHFFFAOYSA-N 0.000 claims 29
- 125000004076 pyridyl group Chemical group 0.000 claims 23
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 20
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 17
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 11
- 125000000623 heterocyclic group Chemical group 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 9
- ZXRCAYWYTOIRQS-UHFFFAOYSA-N hydron;phenol;chloride Chemical compound Cl.OC1=CC=CC=C1 ZXRCAYWYTOIRQS-UHFFFAOYSA-N 0.000 claims 8
- OXDLBBKNAAFZNI-UHFFFAOYSA-N phenol;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC1=CC=CC=C1 OXDLBBKNAAFZNI-UHFFFAOYSA-N 0.000 claims 8
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 claims 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 6
- 125000006311 cyclobutyl amino group Chemical group [H]N(*)C1([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 125000005842 heteroatom Chemical group 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 150000002460 imidazoles Chemical class 0.000 claims 5
- GEOWCLRLLWTHDN-UHFFFAOYSA-N phenyl formate Chemical compound O=COC1=CC=CC=C1 GEOWCLRLLWTHDN-UHFFFAOYSA-N 0.000 claims 5
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- YGTAZGSLCXNBQL-UHFFFAOYSA-N 1,2,4-thiadiazole Chemical compound C=1N=CSN=1 YGTAZGSLCXNBQL-UHFFFAOYSA-N 0.000 claims 4
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 claims 4
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 4
- VRESBNUEIKZECD-UHFFFAOYSA-N 2-methyltetrazole Chemical compound CN1N=CN=N1 VRESBNUEIKZECD-UHFFFAOYSA-N 0.000 claims 4
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N 4-methylimidazole Chemical compound CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 claims 4
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 4
- UQFQONCQIQEYPJ-UHFFFAOYSA-N N-methylpyrazole Chemical compound CN1C=CC=N1 UQFQONCQIQEYPJ-UHFFFAOYSA-N 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 claims 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 3
- 125000000033 alkoxyamino group Chemical group 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- AYEMKBIEDPMVLE-UHFFFAOYSA-N phenol;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC1=CC=CC=C1 AYEMKBIEDPMVLE-UHFFFAOYSA-N 0.000 claims 3
- 125000002098 pyridazinyl group Chemical group 0.000 claims 3
- 125000004514 1,2,4-thiadiazolyl group Chemical group 0.000 claims 2
- 125000004530 1,2,4-triazinyl group Chemical group N1=NC(=NC=C1)* 0.000 claims 2
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 claims 2
- JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical compound C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 claims 2
- 125000003363 1,3,5-triazinyl group Chemical group N1=C(N=CN=C1)* 0.000 claims 2
- 125000005871 1,3-benzodioxolyl group Chemical group 0.000 claims 2
- 125000000355 1,3-benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 2
- CSUGQXMRKOKBFI-UHFFFAOYSA-N 1-methylindazole Chemical compound C1=CC=C2N(C)N=CC2=C1 CSUGQXMRKOKBFI-UHFFFAOYSA-N 0.000 claims 2
- AZWPZEGGNCFEKN-UHFFFAOYSA-N 1-methylpyrazolo[3,4-b]pyridine Chemical compound C1=CN=C2N(C)N=CC2=C1 AZWPZEGGNCFEKN-UHFFFAOYSA-N 0.000 claims 2
- 125000005955 1H-indazolyl group Chemical group 0.000 claims 2
- GDUVBKSVYWFWGV-UHFFFAOYSA-N 2-(1h-pyrazol-4-yl)phenol Chemical compound OC1=CC=CC=C1C1=CNN=C1 GDUVBKSVYWFWGV-UHFFFAOYSA-N 0.000 claims 2
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 claims 2
- NGCXHCGUQHIOLZ-UHFFFAOYSA-N 2-methyltriazole Chemical compound CN1N=CC=N1 NGCXHCGUQHIOLZ-UHFFFAOYSA-N 0.000 claims 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- XKVUYEYANWFIJX-UHFFFAOYSA-N 5-methyl-1h-pyrazole Chemical compound CC1=CC=NN1 XKVUYEYANWFIJX-UHFFFAOYSA-N 0.000 claims 2
- XZGLNCKSNVGDNX-UHFFFAOYSA-N 5-methyl-2h-tetrazole Chemical compound CC=1N=NNN=1 XZGLNCKSNVGDNX-UHFFFAOYSA-N 0.000 claims 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 2
- 229910052805 deuterium Inorganic materials 0.000 claims 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 125000002971 oxazolyl group Chemical group 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 125000004193 piperazinyl group Chemical group 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 claims 1
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 claims 1
- 125000005960 1,4-diazepanyl group Chemical group 0.000 claims 1
- KXSIGCKZTIHSHU-UHFFFAOYSA-N 1-[1-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]imidazol-4-yl]ethanone Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=NC(=C1)C(C)=O KXSIGCKZTIHSHU-UHFFFAOYSA-N 0.000 claims 1
- SYQTZXSPALHUDB-UHFFFAOYSA-N 1-[1-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]imidazol-4-yl]ethanone dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-n1cnc(c1)C(C)=O SYQTZXSPALHUDB-UHFFFAOYSA-N 0.000 claims 1
- IOGRSYJMACDTCZ-UHFFFAOYSA-N 1-[1-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]pyrazol-4-yl]ethanone Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=C(C=N1)C(C)=O IOGRSYJMACDTCZ-UHFFFAOYSA-N 0.000 claims 1
- QBFIYMLATFUYIN-UHFFFAOYSA-N 1-[1-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]pyrazol-4-yl]ethanone dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-n1cc(cn1)C(C)=O QBFIYMLATFUYIN-UHFFFAOYSA-N 0.000 claims 1
- WKUSMYTZYNHVKC-UHFFFAOYSA-N 1-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]imidazole-4-carbonitrile Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=NC(=C1)C#N WKUSMYTZYNHVKC-UHFFFAOYSA-N 0.000 claims 1
- BFHIDFGQEWLRDR-UHFFFAOYSA-N 1-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]pyrazol-4-ol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=C(O)C=N1 BFHIDFGQEWLRDR-UHFFFAOYSA-N 0.000 claims 1
- LAGKHQLJJAISGX-UHFFFAOYSA-N 1-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]pyrazole-4-carbonitrile Chemical compound C1=C(C=NN1C1=CC(=C(C2=CN=C(N=N2)N(C2CC(C)(C)NC(C2)(C)C)C)C=C1)O)C#N LAGKHQLJJAISGX-UHFFFAOYSA-N 0.000 claims 1
- UKHJNJFJCGBKSF-UHFFFAOYSA-N 2,5-diazabicyclo[2.2.1]heptane Chemical compound C1NC2CNC1C2 UKHJNJFJCGBKSF-UHFFFAOYSA-N 0.000 claims 1
- RTRXUXZHOIUUOF-UHFFFAOYSA-N 2-(3-piperazin-1-yl-1,2,4-triazin-6-yl)-5-(1H-pyrazol-4-yl)phenol Chemical compound N1(CCNCC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O RTRXUXZHOIUUOF-UHFFFAOYSA-N 0.000 claims 1
- BIASHOJVOWHKAG-UHFFFAOYSA-N 2-(3-piperazin-1-yl-1,2,4-triazin-6-yl)-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCNCC1)-c1cn[nH]c1 BIASHOJVOWHKAG-UHFFFAOYSA-N 0.000 claims 1
- IYTJXWUIRIBQOY-UHFFFAOYSA-N 2-[3-(1,7-diazaspiro[4.4]nonan-7-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC2(CCCN2)C1 IYTJXWUIRIBQOY-UHFFFAOYSA-N 0.000 claims 1
- KOZMLNLEWQCQGL-UHFFFAOYSA-N 2-[3-(1,7-diazaspiro[4.4]nonan-7-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCC2(CCCN2)C1)-c1cn[nH]c1 KOZMLNLEWQCQGL-UHFFFAOYSA-N 0.000 claims 1
- TTXKQIMDHRHKAO-UHFFFAOYSA-N 2-[3-(2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrol-5-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CC2CCNC2C1 TTXKQIMDHRHKAO-UHFFFAOYSA-N 0.000 claims 1
- JCODCOCZGCQGKJ-UHFFFAOYSA-N 2-[3-(2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CC2CNCC2C1 JCODCOCZGCQGKJ-UHFFFAOYSA-N 0.000 claims 1
- HOYGMBCMNZNKSI-UHFFFAOYSA-N 2-[3-(2,6-diazaspiro[3.3]heptan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C1N(CC11CNC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O HOYGMBCMNZNKSI-UHFFFAOYSA-N 0.000 claims 1
- LHSPHGOHZVYXHN-UHFFFAOYSA-N 2-[3-(2,6-diazaspiro[3.3]heptan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CC2(CNC2)C1)-c1cn[nH]c1 LHSPHGOHZVYXHN-UHFFFAOYSA-N 0.000 claims 1
- KDAYHQLPHNLWIG-UHFFFAOYSA-N 2-[3-(2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC2(CNC2)C1 KDAYHQLPHNLWIG-UHFFFAOYSA-N 0.000 claims 1
- QLWOFFHFHNUPOC-UHFFFAOYSA-N 2-[3-(2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCC2(CNC2)C1)-c1cn[nH]c1 QLWOFFHFHNUPOC-UHFFFAOYSA-N 0.000 claims 1
- XWCQKJQLZATXPQ-UHFFFAOYSA-N 2-[3-(2,6-dimethylpiperidin-4-yl)oxy-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CC1NC(CC(C1)OC=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O)C XWCQKJQLZATXPQ-UHFFFAOYSA-N 0.000 claims 1
- KYHHCKWWXOYGBJ-UHFFFAOYSA-N 2-[3-(2,6-dimethylpiperidin-4-yl)oxy-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CC1CC(CC(C)N1)Oc1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 KYHHCKWWXOYGBJ-UHFFFAOYSA-N 0.000 claims 1
- ZKAXNMKZMWKZJV-UHFFFAOYSA-N 2-[3-(2,7-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CC2(C1)CCNCC2 ZKAXNMKZMWKZJV-UHFFFAOYSA-N 0.000 claims 1
- CGQSMGNLJUXZCR-UHFFFAOYSA-N 2-[3-(2,7-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CC2(C1)CCNCC2)-c1cn[nH]c1 CGQSMGNLJUXZCR-UHFFFAOYSA-N 0.000 claims 1
- PWPFXPSTCYANTD-UHFFFAOYSA-N 2-[3-(2,7-diazaspiro[3.5]nonan-7-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC2(CNC2)CC1 PWPFXPSTCYANTD-UHFFFAOYSA-N 0.000 claims 1
- JKPLNMKPIISUPR-UHFFFAOYSA-N 2-[3-(2,7-diazaspiro[3.5]nonan-7-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCC2(CNC2)CC1)-c1cn[nH]c1 JKPLNMKPIISUPR-UHFFFAOYSA-N 0.000 claims 1
- ZFDHVRLQWPRPNE-UHFFFAOYSA-N 2-[3-(2,7-diazaspiro[4.4]nonan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC2(CCNC2)C1 ZFDHVRLQWPRPNE-UHFFFAOYSA-N 0.000 claims 1
- DXDUWHWNDBYIDZ-UHFFFAOYSA-N 2-[3-(2,7-diazaspiro[4.4]nonan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCC2(CCNC2)C1)-c1cn[nH]c1 DXDUWHWNDBYIDZ-UHFFFAOYSA-N 0.000 claims 1
- PHYSFFVRTLXKAK-UHFFFAOYSA-N 2-[3-(2,8-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CC2(C1)CCCNC2 PHYSFFVRTLXKAK-UHFFFAOYSA-N 0.000 claims 1
- FVIRDPLNRYHCRU-UHFFFAOYSA-N 2-[3-(2,8-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CC2(C1)CCCNC2)-c1cn[nH]c1 FVIRDPLNRYHCRU-UHFFFAOYSA-N 0.000 claims 1
- JBQOTZQLNDVXRN-UHFFFAOYSA-N 2-[3-(2,8-diazaspiro[4.5]decan-8-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC2(CCNC2)CC1 JBQOTZQLNDVXRN-UHFFFAOYSA-N 0.000 claims 1
- ZDSMJENOMKGLGY-UHFFFAOYSA-N 2-[3-(2,8-diazaspiro[4.5]decan-8-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCC2(CCNC2)CC1)-c1cn[nH]c1 ZDSMJENOMKGLGY-UHFFFAOYSA-N 0.000 claims 1
- UQOJYKHOTKKMBD-UHFFFAOYSA-N 2-[3-(2,9-diazaspiro[4.5]decan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC2(C1)CCCNC2 UQOJYKHOTKKMBD-UHFFFAOYSA-N 0.000 claims 1
- GTQBAFJMSFWJHX-UHFFFAOYSA-N 2-[3-(2,9-diazaspiro[4.5]decan-2-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCC2(C1)CCCNC2)-c1cn[nH]c1 GTQBAFJMSFWJHX-UHFFFAOYSA-N 0.000 claims 1
- SKMPTKZJIXKLQW-UHFFFAOYSA-N 2-[3-(2,9-diazaspiro[5.5]undecan-9-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC2(CCCNC2)CC1 SKMPTKZJIXKLQW-UHFFFAOYSA-N 0.000 claims 1
- QWTMWUQVVSUSTQ-UHFFFAOYSA-N 2-[3-(2,9-diazaspiro[5.5]undecan-9-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCC2(CCCNC2)CC1)-c1cn[nH]c1 QWTMWUQVVSUSTQ-UHFFFAOYSA-N 0.000 claims 1
- AOYVPCCFLIVVIV-UHFFFAOYSA-N 2-[3-(3,5-dimethylpiperazin-1-yl)-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-3-yl)phenol Chemical compound CC1CN(CC(N1)C)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C1=NN(C=C1)C)O AOYVPCCFLIVVIV-UHFFFAOYSA-N 0.000 claims 1
- VBKRSVWKRSKNGX-UHFFFAOYSA-N 2-[3-(3,5-dimethylpiperazin-1-yl)-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-3-yl)phenol hydrochloride Chemical compound Cl.CC1CN(CC(C)N1)c1ncc(nn1)-c1ccc(cc1O)-c1ccn(C)n1 VBKRSVWKRSKNGX-UHFFFAOYSA-N 0.000 claims 1
- VYFITHDPFHQHHH-UHFFFAOYSA-N 2-[3-(3,5-dimethylpiperazin-1-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CC1CN(CC(N1)C)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O VYFITHDPFHQHHH-UHFFFAOYSA-N 0.000 claims 1
- BHCCWBJRKJRLLD-UHFFFAOYSA-N 2-[3-(3,5-dimethylpiperazin-1-yl)-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CC1CN(CC(C)N1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 BHCCWBJRKJRLLD-UHFFFAOYSA-N 0.000 claims 1
- LCMKGEJNRHCSTC-UHFFFAOYSA-N 2-[3-(3-amino-3-methylpyrrolidin-1-yl)-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-4-yl)phenol Chemical compound CN1C=C(C=N1)C1=CC(O)=C(C=C1)C1=CN=C(N=N1)N1CCC(C)(N)C1 LCMKGEJNRHCSTC-UHFFFAOYSA-N 0.000 claims 1
- OINCWCUVSOGRFZ-UHFFFAOYSA-N 2-[3-(7-methyl-2,7-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]-5-pyrimidin-2-ylphenol Chemical compound CN1CCC2(CN(C2)C2=NC=C(N=N2)C2=C(O)C=C(C=C2)C2=NC=CC=N2)CC1 OINCWCUVSOGRFZ-UHFFFAOYSA-N 0.000 claims 1
- RUUKEZNHLWNXAZ-UHFFFAOYSA-N 2-[3-(7-methyl-2,7-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]-5-pyrimidin-2-ylphenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CN1CCC2(CN(C2)c2ncc(nn2)-c2ccc(cc2O)-c2ncccn2)CC1 RUUKEZNHLWNXAZ-UHFFFAOYSA-N 0.000 claims 1
- CUPRXSAQLOXUPY-UHFFFAOYSA-N 2-[3-[(1-methylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CN1CCC(CC1)NC1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 CUPRXSAQLOXUPY-UHFFFAOYSA-N 0.000 claims 1
- BKAQFANKJMHEHR-UHFFFAOYSA-N 2-[3-[(1-methylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol trihydrochloride Chemical compound Cl.Cl.Cl.CN1CCC(CC1)NC=1N=NC(=CN1)C1=C(C=C(C=C1)C=1C=NNC1)O BKAQFANKJMHEHR-UHFFFAOYSA-N 0.000 claims 1
- KUXTXWOIEWDRGW-UHFFFAOYSA-N 2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-(1,2,4-triazin-6-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1(C)CC(CC(C)(C)N1)Nc1ncc(nn1)-c1ccc(cc1O)-c1cncnn1 KUXTXWOIEWDRGW-UHFFFAOYSA-N 0.000 claims 1
- LKMQHHWRKPYYSE-UHFFFAOYSA-N 2-[3-[(3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-(triazol-2-yl)phenol Chemical compound CC1(C)CC(NC2=NC=C(N=N2)C2=C(O)C=C(C=C2)N2N=CC=N2)C(F)C(C)(C)N1 LKMQHHWRKPYYSE-UHFFFAOYSA-N 0.000 claims 1
- FNXHTMAKPFTNII-MRXNPFEDSA-N 2-[3-[(3R)-3-(cyclobutylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound N1N=CC(=C1)C1=CC=C(C2=CN=C(N=N2)N2C[C@H](NC3CCC3)CC2)C(O)=C1 FNXHTMAKPFTNII-MRXNPFEDSA-N 0.000 claims 1
- AJPYPUUUHOYAEV-OAHLLOKOSA-N 2-[3-[(3R)-3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)N[C@H]1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O AJPYPUUUHOYAEV-OAHLLOKOSA-N 0.000 claims 1
- YUCTWSACDXMXCY-QCUBGVIVSA-N 2-[3-[(3R)-3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound CC(C)(C)N[C@@H]1CCN(C1)C2=NC=C(N=N2)C3=C(C=C(C=C3)C4=CNN=C4)O.Cl.Cl YUCTWSACDXMXCY-QCUBGVIVSA-N 0.000 claims 1
- FXMVZFYAHLMTTD-ZDUSSCGKSA-N 2-[3-[(3S)-1-methylpyrrolidin-3-yl]oxy-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CN1CC[C@@H](C1)OC1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 FXMVZFYAHLMTTD-ZDUSSCGKSA-N 0.000 claims 1
- NNMUAHGDYSOGQG-ZOWNYOTGSA-N 2-[3-[(3S)-1-methylpyrrolidin-3-yl]oxy-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol hydrochloride Chemical compound Cl.CN1CC[C@@H](C1)Oc1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 NNMUAHGDYSOGQG-ZOWNYOTGSA-N 0.000 claims 1
- FNXHTMAKPFTNII-INIZCTEOSA-N 2-[3-[(3S)-3-(cyclobutylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound Oc1cc(ccc1-c1cnc(nn1)N1CC[C@@H](C1)NC1CCC1)-c1cn[nH]c1 FNXHTMAKPFTNII-INIZCTEOSA-N 0.000 claims 1
- QZAUQAZOXKSADX-ZDUSSCGKSA-N 2-[3-[(3S)-3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CN[C@@H]1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O QZAUQAZOXKSADX-ZDUSSCGKSA-N 0.000 claims 1
- CDALUHTXKLNBJQ-GXKRWWSZSA-N 2-[3-[(3S)-3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CN[C@H]1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 CDALUHTXKLNBJQ-GXKRWWSZSA-N 0.000 claims 1
- AJPYPUUUHOYAEV-HNNXBMFYSA-N 2-[3-[(3S)-3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CC(C)(C)N[C@H]1CCN(C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 AJPYPUUUHOYAEV-HNNXBMFYSA-N 0.000 claims 1
- YUCTWSACDXMXCY-CKUXDGONSA-N 2-[3-[(3S)-3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.C(C)(C)(C)N[C@@H]1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C=1C=NNC1)O YUCTWSACDXMXCY-CKUXDGONSA-N 0.000 claims 1
- FJDRQVJAQBLACX-DOMZBBRYSA-N 2-[3-[(3S)-3-[[(2R)-1-fluoropropan-2-yl]amino]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound FC[C@@H](C)N[C@@H]1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O FJDRQVJAQBLACX-DOMZBBRYSA-N 0.000 claims 1
- IAMKMCQYYYUVQM-DKSSEZFCSA-N 2-[3-[(3aR,4R,6aS)-4-(dimethylamino)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CN([C@@H]1CC[C@@H]2CN(C[C@@H]21)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O)C IAMKMCQYYYUVQM-DKSSEZFCSA-N 0.000 claims 1
- RAIONFDGXQOYOF-WBNIKMCISA-N 2-[3-[(3aR,4R,6aS)-4-(dimethylamino)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound CN(C)[C@@H]1CC[C@H]2[C@@H]1CN(C2)C3=NC=C(N=N3)C4=C(C=C(C=C4)C5=CNN=C5)O.Cl.Cl RAIONFDGXQOYOF-WBNIKMCISA-N 0.000 claims 1
- JAGWTUBTIQKLDR-AYOQOUSVSA-N 2-[3-[(3aR,4R,6aS)-4-(tert-butylamino)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)N[C@@H]1CC[C@@H]2CN(C[C@@H]21)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O JAGWTUBTIQKLDR-AYOQOUSVSA-N 0.000 claims 1
- VOYMBWAXLSRTMB-WUCMLCBTSA-N 2-[3-[(3aR,4R,6aS)-4-(tert-butylamino)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound CC(C)(C)N[C@@H]1CC[C@H]2[C@@H]1CN(C2)C3=NC=C(N=N3)C4=C(C=C(C=C4)C5=CNN=C5)O.Cl.Cl VOYMBWAXLSRTMB-WUCMLCBTSA-N 0.000 claims 1
- IAMKMCQYYYUVQM-LJHODMEESA-N 2-[3-[(3aR,4S,6aS)-4-(dimethylamino)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CN([C@H]1CC[C@@H]2CN(C[C@@H]21)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O)C IAMKMCQYYYUVQM-LJHODMEESA-N 0.000 claims 1
- RAIONFDGXQOYOF-RIOSZLGWSA-N 2-[3-[(3aR,4S,6aS)-4-(dimethylamino)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound CN(C)[C@H]1CC[C@H]2[C@@H]1CN(C2)C3=NC=C(N=N3)C4=C(C=C(C=C4)C5=CNN=C5)O.Cl.Cl RAIONFDGXQOYOF-RIOSZLGWSA-N 0.000 claims 1
- IAYUEDCPUOUENV-SUMWQHHRSA-N 2-[3-[(3aS,7aR)-1-methyl-3,3a,4,6,7,7a-hexahydro-2H-pyrrolo[3,2-c]pyridin-5-yl]-1,2,4-triazin-6-yl]-5-(5-fluoro-1H-pyrazol-4-yl)phenol Chemical compound CN1CC[C@H]2CN(CC[C@@H]12)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1F IAYUEDCPUOUENV-SUMWQHHRSA-N 0.000 claims 1
- JUQUJFJQGMEKOL-YUANJJMISA-N 2-[3-[(3aS,7aR)-1-methyl-3,3a,4,6,7,7a-hexahydro-2H-pyrrolo[3,2-c]pyridin-5-yl]-1,2,4-triazin-6-yl]-5-(5-fluoro-1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound CN1CC[C@@H]2[C@H]1CCN(C2)C3=NC=C(N=N3)C4=C(C=C(C=C4)C5=C(NN=C5)F)O.Cl.Cl JUQUJFJQGMEKOL-YUANJJMISA-N 0.000 claims 1
- UONQSHIUWMLZCR-UHFFFAOYSA-N 2-[3-[3-(1-adamantylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC(C1)NC12CC3CC(CC(C3)C1)C2 UONQSHIUWMLZCR-UHFFFAOYSA-N 0.000 claims 1
- NYOHULCLGPUAPL-UHFFFAOYSA-N 2-[3-[3-(1-adamantylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.Oc1cc(ccc1-c1cnc(nn1)N1CCC(C1)NC12CC3CC(CC(C3)C1)C2)-c1cn[nH]c1 NYOHULCLGPUAPL-UHFFFAOYSA-N 0.000 claims 1
- WZZBGCOGRIAKKK-UHFFFAOYSA-N 2-[3-[3-(2-adamantylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC(C1)NC1C2CC3CC(C2)CC1C3 WZZBGCOGRIAKKK-UHFFFAOYSA-N 0.000 claims 1
- GTYWJZCUEHDKJO-UHFFFAOYSA-N 2-[3-[3-(2-adamantylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.Oc1cc(ccc1-c1cnc(nn1)N1CCC(C1)NC1C2CC3CC(C2)CC1C3)-c1cn[nH]c1 GTYWJZCUEHDKJO-UHFFFAOYSA-N 0.000 claims 1
- SNDXZPPVOYHPNT-UHFFFAOYSA-N 2-[3-[3-(2-hydroxyethylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OCCNC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O SNDXZPPVOYHPNT-UHFFFAOYSA-N 0.000 claims 1
- JQSVJNYCSYGUSU-UHFFFAOYSA-N 2-[3-[3-(2-methylpropylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CC(CNC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O)C JQSVJNYCSYGUSU-UHFFFAOYSA-N 0.000 claims 1
- MGSGQJPCORKJBB-UHFFFAOYSA-N 2-[3-[3-(cyclopentylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C1(CCCC1)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O MGSGQJPCORKJBB-UHFFFAOYSA-N 0.000 claims 1
- MMMQEUVRIQSZCJ-UHFFFAOYSA-N 2-[3-[3-(cyclopentylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCC(C1)NC1CCCC1)-c1cn[nH]c1 MMMQEUVRIQSZCJ-UHFFFAOYSA-N 0.000 claims 1
- ZGRHAIUTHXIGDF-UHFFFAOYSA-N 2-[3-[3-(cyclopropylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C1(CC1)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O ZGRHAIUTHXIGDF-UHFFFAOYSA-N 0.000 claims 1
- WIUSGQOBOBPTFK-UHFFFAOYSA-N 2-[3-[3-(dimethylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CN(C1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O)C WIUSGQOBOBPTFK-UHFFFAOYSA-N 0.000 claims 1
- SICRLYUBKWVVKG-UHFFFAOYSA-N 2-[3-[3-(ethylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O SICRLYUBKWVVKG-UHFFFAOYSA-N 0.000 claims 1
- GDDPNLAKSGTSMQ-UHFFFAOYSA-N 2-[3-[3-(ethylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CCNC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 GDDPNLAKSGTSMQ-UHFFFAOYSA-N 0.000 claims 1
- FKPKVANVZUHXQS-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1,2,4-thiadiazol-5-yl)phenol Chemical compound CNC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C1=NC=NS1)O FKPKVANVZUHXQS-UHFFFAOYSA-N 0.000 claims 1
- GNVIMVBRAQYCAH-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1,2,4-thiadiazol-5-yl)phenol dihydrochloride Chemical compound Cl.Cl.CNC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1ncns1 GNVIMVBRAQYCAH-UHFFFAOYSA-N 0.000 claims 1
- CEHGOSPESNJJPG-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1,3-oxazol-2-yl)phenol Chemical compound CNC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1OC=CN=1)O CEHGOSPESNJJPG-UHFFFAOYSA-N 0.000 claims 1
- RVHZPYOZUQZDIW-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1,3-oxazol-2-yl)phenol dihydrochloride Chemical compound Cl.Cl.CNC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1ncco1 RVHZPYOZUQZDIW-UHFFFAOYSA-N 0.000 claims 1
- REEDJMNARLFAAD-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-3-yl)phenol Chemical compound CNC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C1=NN(C=C1)C)O REEDJMNARLFAAD-UHFFFAOYSA-N 0.000 claims 1
- SCWOVMGNMDPXTB-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-3-yl)phenol dihydrochloride Chemical compound Cl.Cl.CNC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1ccn(C)n1 SCWOVMGNMDPXTB-UHFFFAOYSA-N 0.000 claims 1
- BIWCMXHYBHXAKI-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-4-yl)phenol Chemical compound CNC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NN(C=1)C)O BIWCMXHYBHXAKI-UHFFFAOYSA-N 0.000 claims 1
- HNGCBLUEWVOFCW-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-4-yl)phenol hydrochloride Chemical compound Cl.CNC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1cnn(C)c1 HNGCBLUEWVOFCW-UHFFFAOYSA-N 0.000 claims 1
- XBYIETAMTPAORA-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(2-methyl-1,3-oxazol-5-yl)phenol dihydrochloride Chemical compound Cl.Cl.CNC1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C1=CN=C(O1)C)O XBYIETAMTPAORA-UHFFFAOYSA-N 0.000 claims 1
- DXTLPQAEKQREFD-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(2-methyltetrazol-5-yl)phenol trihydrochloride Chemical compound Cl.Cl.Cl.CNC1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C=1N=NN(N1)C)O DXTLPQAEKQREFD-UHFFFAOYSA-N 0.000 claims 1
- IMJWYJUHNAWGJG-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(6-methylsulfanylpyrimidin-4-yl)phenol Chemical compound CNC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C1=NC=NC(=C1)SC)O IMJWYJUHNAWGJG-UHFFFAOYSA-N 0.000 claims 1
- HOHTWHHAOXMLPQ-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(6-methylsulfanylpyrimidin-4-yl)phenol trihydrochloride Chemical compound Cl.Cl.Cl.CNC1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C1=NC=NC(=C1)SC)O HOHTWHHAOXMLPQ-UHFFFAOYSA-N 0.000 claims 1
- PGZRWPHUXYQECF-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(triazol-2-yl)phenol Chemical compound CNC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)N1N=CC=N1)O PGZRWPHUXYQECF-UHFFFAOYSA-N 0.000 claims 1
- MCNJFKZWFHFEPM-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-pyrimidin-2-ylphenol Chemical compound CNC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C1=NC=CC=N1)O MCNJFKZWFHFEPM-UHFFFAOYSA-N 0.000 claims 1
- YZNPXHHXXNQEPU-UHFFFAOYSA-N 2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-pyrimidin-2-ylphenol dihydrochloride Chemical compound Cl.Cl.CNC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1ncccn1 YZNPXHHXXNQEPU-UHFFFAOYSA-N 0.000 claims 1
- FHMLOBOZJYFZLX-UHFFFAOYSA-N 2-[3-[3-(methylaminomethyl)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound N1N=CC(=C1)C1=CC=C(C2=CN=C(N=N2)N2CC(CNC)CC2)C(O)=C1 FHMLOBOZJYFZLX-UHFFFAOYSA-N 0.000 claims 1
- LIJFXMYLJBJQRN-UHFFFAOYSA-N 2-[3-[3-(methylaminomethyl)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CNCC1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C=1C=NNC1)O LIJFXMYLJBJQRN-UHFFFAOYSA-N 0.000 claims 1
- FXOJZUKQPDKQBQ-UHFFFAOYSA-N 2-[3-[3-(oxan-4-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound O1CCC(CC1)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O FXOJZUKQPDKQBQ-UHFFFAOYSA-N 0.000 claims 1
- VZVQEGBOOCGDMW-UHFFFAOYSA-N 2-[3-[3-(oxan-4-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Oc1cc(ccc1-c1cnc(nn1)N1CCC(C1)NC1CCOCC1)-c1cn[nH]c1 VZVQEGBOOCGDMW-UHFFFAOYSA-N 0.000 claims 1
- CZAKLFZABOAOAC-UHFFFAOYSA-N 2-[3-[3-(oxetan-3-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound O1CC(C1)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O CZAKLFZABOAOAC-UHFFFAOYSA-N 0.000 claims 1
- PLHNNFXUQRMQAF-UHFFFAOYSA-N 2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CC(C)NC1CCN(C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 PLHNNFXUQRMQAF-UHFFFAOYSA-N 0.000 claims 1
- CHBHGHQUYUVSKC-UHFFFAOYSA-N 2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol hydrochloride Chemical compound Cl.CC(C)NC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 CHBHGHQUYUVSKC-UHFFFAOYSA-N 0.000 claims 1
- KPMRMNZQERYAJI-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)-4-fluoropyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1F)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O KPMRMNZQERYAJI-UHFFFAOYSA-N 0.000 claims 1
- VRPDQQCHIYMIPX-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)-4-fluoropyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol hydrochloride Chemical compound Cl.CC(C)(C)NC1CN(CC1F)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 VRPDQQCHIYMIPX-UHFFFAOYSA-N 0.000 claims 1
- SSLQNKKGXQHXQR-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)piperidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CCC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O SSLQNKKGXQHXQR-UHFFFAOYSA-N 0.000 claims 1
- WMUNPMQDLBEWAH-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)piperidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(C)(C)NC1CCCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 WMUNPMQDLBEWAH-UHFFFAOYSA-N 0.000 claims 1
- CEUBWZFXBHYKEV-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-3-methoxy-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1OC)C=1C=NNC=1)O CEUBWZFXBHYKEV-UHFFFAOYSA-N 0.000 claims 1
- MTTOPERRMHRNTB-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-3-methoxy-5-(1H-pyrazol-4-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COc1cc(cc(O)c1-c1cnc(nn1)N1CCC(C1)NC(C)(C)C)-c1cn[nH]c1 MTTOPERRMHRNTB-UHFFFAOYSA-N 0.000 claims 1
- MWYYKCSMUGGTAH-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1,3-oxazol-2-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1OC=CN=1)O MWYYKCSMUGGTAH-UHFFFAOYSA-N 0.000 claims 1
- XHKGBAGQHMOUQD-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1,3-oxazol-2-yl)phenol hydrochloride Chemical compound Cl.CC(C)(C)NC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1ncco1 XHKGBAGQHMOUQD-UHFFFAOYSA-N 0.000 claims 1
- XVLPCENXSJBARU-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1-methylindazol-5-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=C2C=NN(C2=CC=1)C)O XVLPCENXSJBARU-UHFFFAOYSA-N 0.000 claims 1
- GGOHVVKDPXITOF-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1-methylindazol-5-yl)phenol dihydrochloride Chemical compound Cl.Cl.Cn1ncc2cc(ccc12)-c1ccc(c(O)c1)-c1cnc(nn1)N1CCC(C1)NC(C)(C)C GGOHVVKDPXITOF-UHFFFAOYSA-N 0.000 claims 1
- UUSQVLANZCENME-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-3-yl)phenol Chemical compound Cn1ccc(n1)-c1ccc(c(O)c1)-c1cnc(nn1)N1CCC(C1)NC(C)(C)C UUSQVLANZCENME-UHFFFAOYSA-N 0.000 claims 1
- MLDFJWIZOFENAK-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NN(C=1)C)O MLDFJWIZOFENAK-UHFFFAOYSA-N 0.000 claims 1
- CLQZJKBWYFKFMF-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1-methyltriazolo[4,5-b]pyridin-5-yl)phenol Chemical compound CN1N=NC2=C1C=CC(=N2)C1=CC(O)=C(C=C1)C1=CN=C(N=N1)N1CCC(C1)NC(C)(C)C CLQZJKBWYFKFMF-UHFFFAOYSA-N 0.000 claims 1
- AJPYPUUUHOYAEV-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O AJPYPUUUHOYAEV-UHFFFAOYSA-N 0.000 claims 1
- ZWGCPXFIZLMBFU-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(2-methyltetrazol-5-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1N=NN(N=1)C)O ZWGCPXFIZLMBFU-UHFFFAOYSA-N 0.000 claims 1
- CWFUSDXAYCUZRR-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(2-methyltetrazol-5-yl)phenol dihydrochloride Chemical compound Cl.Cl.Cn1nnc(n1)-c1ccc(c(O)c1)-c1cnc(nn1)N1CCC(C1)NC(C)(C)C CWFUSDXAYCUZRR-UHFFFAOYSA-N 0.000 claims 1
- IVTSINSHNCOZCS-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(4-methylimidazol-1-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)N1C=NC(=C1)C)O IVTSINSHNCOZCS-UHFFFAOYSA-N 0.000 claims 1
- NWIRKKRVRKBXLU-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(5-chloro-1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C(=NNC=1)Cl)O NWIRKKRVRKBXLU-UHFFFAOYSA-N 0.000 claims 1
- YCKKUIPBMQTRTJ-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(5-chloro-1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CC(C)(C)NC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1Cl YCKKUIPBMQTRTJ-UHFFFAOYSA-N 0.000 claims 1
- KBARCCPICPLBAC-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(5-fluoro-1H-pyrazol-4-yl)phenol Chemical compound CC(C)(C)NC1CCN(C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1F KBARCCPICPLBAC-UHFFFAOYSA-N 0.000 claims 1
- YPYUQXDHIDTUSP-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(5-methyl-1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C(=NNC=1)C)O YPYUQXDHIDTUSP-UHFFFAOYSA-N 0.000 claims 1
- LJCDXBDZUQFSQB-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(5-methyl-1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.Cc1[nH]ncc1-c1ccc(c(O)c1)-c1cnc(nn1)N1CCC(C1)NC(C)(C)C LJCDXBDZUQFSQB-UHFFFAOYSA-N 0.000 claims 1
- SIJQDWRPERLFCE-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(6-methoxypyrimidin-4-yl)phenol Chemical compound N1=C(C=C(N=C1)C1=CC=C(C2=CN=C(N=N2)N2CCC(NC(C)(C)C)C2)C(O)=C1)OC SIJQDWRPERLFCE-UHFFFAOYSA-N 0.000 claims 1
- MLDFJWIZOFENAK-GKOSEXJESA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NN(C=1)C([2H])([2H])[2H])O MLDFJWIZOFENAK-GKOSEXJESA-N 0.000 claims 1
- VNNXTUYFGFIJOV-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-imidazol-1-ylphenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)N1C=NC=C1)O VNNXTUYFGFIJOV-UHFFFAOYSA-N 0.000 claims 1
- UMRRXAGJSDHRHA-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-imidazol-1-ylphenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CC(C)(C)NC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-n1ccnc1 UMRRXAGJSDHRHA-UHFFFAOYSA-N 0.000 claims 1
- OYIAWNSMOXIBJA-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-pyrimidin-2-ylphenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C1=NC=CC=N1)O OYIAWNSMOXIBJA-UHFFFAOYSA-N 0.000 claims 1
- YLPBPDFBPXEMTR-UHFFFAOYSA-N 2-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-pyrimidin-2-ylphenol dihydrochloride Chemical compound Cl.Cl.CC(C)(C)NC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1ncccn1 YLPBPDFBPXEMTR-UHFFFAOYSA-N 0.000 claims 1
- HVLLLUICYJYLPI-UHFFFAOYSA-N 2-[3-[3-[(1-methylcyclopropyl)amino]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CC1(CC1)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O HVLLLUICYJYLPI-UHFFFAOYSA-N 0.000 claims 1
- NDSAAKUGUXNVCT-UHFFFAOYSA-N 2-[3-[3-[(1-methylcyclopropyl)amino]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CC1(CC1)NC1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C=1C=NNC1)O NDSAAKUGUXNVCT-UHFFFAOYSA-N 0.000 claims 1
- CAZRHJOVYYXPSL-UHFFFAOYSA-N 2-[3-[3-[(3,3-difluorocyclopentyl)amino]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound Oc1cc(ccc1-c1cnc(nn1)N1CCC(C1)NC1CCC(F)(F)C1)-c1cn[nH]c1 CAZRHJOVYYXPSL-UHFFFAOYSA-N 0.000 claims 1
- GOQFFXQBNJORKV-UHFFFAOYSA-N 2-[3-[3-[(3-fluorocyclopentyl)amino]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC(C1)NC1CCC(F)C1 GOQFFXQBNJORKV-UHFFFAOYSA-N 0.000 claims 1
- YYWNWJXOHCEECN-UHFFFAOYSA-N 2-[3-[3-[(cyclobutylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C1(CCC1)NCC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O YYWNWJXOHCEECN-UHFFFAOYSA-N 0.000 claims 1
- ZZCRTPMXGHXJSC-UHFFFAOYSA-N 2-[3-[3-[(cyclobutylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.C1(CCC1)NCC1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C=1C=NNC1)O ZZCRTPMXGHXJSC-UHFFFAOYSA-N 0.000 claims 1
- PSEKHDJBMSJDPU-UHFFFAOYSA-N 2-[3-[3-[(cyclopentylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound OC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC(CNC2CCCC2)C1 PSEKHDJBMSJDPU-UHFFFAOYSA-N 0.000 claims 1
- HJMKAWFYVWOHQE-UHFFFAOYSA-N 2-[3-[3-[(cyclopentylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.C1(CCCC1)NCC1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C=1C=NNC1)O HJMKAWFYVWOHQE-UHFFFAOYSA-N 0.000 claims 1
- KTDGEAYLMRCIQJ-UHFFFAOYSA-N 2-[3-[3-[(cyclopropylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound N=1NC=C(C=1)C1=CC=C(C2=CN=C(N=N2)N2CCC(CNC3CC3)C2)C(O)=C1 KTDGEAYLMRCIQJ-UHFFFAOYSA-N 0.000 claims 1
- NYURIVSVXGJNSW-UHFFFAOYSA-N 2-[3-[3-[(dimethylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound N1C=C(C2=CC=C(C3=CN=C(N4CCC(CN(C)C)C4)N=N3)C(O)=C2)C=N1 NYURIVSVXGJNSW-UHFFFAOYSA-N 0.000 claims 1
- ZSIINFLADFCMBR-UHFFFAOYSA-N 2-[3-[3-[(dimethylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CN(C)CC1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C=1C=NNC1)O ZSIINFLADFCMBR-UHFFFAOYSA-N 0.000 claims 1
- RYTOKFYVQPFHET-UHFFFAOYSA-N 2-[3-[3-[(tert-butylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound N1N=CC(=C1)C1=CC=C(C2=CN=C(N=N2)N2CCC(CNC(C)(C)C)C2)C(O)=C1 RYTOKFYVQPFHET-UHFFFAOYSA-N 0.000 claims 1
- YQUDFQCYKDLCEO-UHFFFAOYSA-N 2-[3-[4-(tert-butylamino)-2-methylpyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CC(N(C1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O)C YQUDFQCYKDLCEO-UHFFFAOYSA-N 0.000 claims 1
- XWLMPBOIEIOSKB-UHFFFAOYSA-N 2-[3-[4-(tert-butylamino)piperidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CCN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O XWLMPBOIEIOSKB-UHFFFAOYSA-N 0.000 claims 1
- SYWHCNUQDZDLIG-UHFFFAOYSA-N 2-[3-[4-(tert-butylamino)piperidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC(C)(C)NC1CCN(CC1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 SYWHCNUQDZDLIG-UHFFFAOYSA-N 0.000 claims 1
- SPUUSLXEIQIVER-JTQLQIEISA-N 2-[3-[[(2S)-2-aminopropyl]-methylamino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C[C@H](N)CN(C)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 SPUUSLXEIQIVER-JTQLQIEISA-N 0.000 claims 1
- ZBLHLSAKRWDMSY-XRIOVQLTSA-N 2-[3-[[(2S)-2-aminopropyl]-methylamino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.C[C@H](N)CN(C)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 ZBLHLSAKRWDMSY-XRIOVQLTSA-N 0.000 claims 1
- JZVWLFOAZASBMO-CRAIPNDOSA-N 2-[3-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound F[C@H]1C(NC(C[C@H]1NC=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O)(C)C)(C)C JZVWLFOAZASBMO-CRAIPNDOSA-N 0.000 claims 1
- QHBAPJSQFSZDCL-KGLIPLIRSA-N 2-[3-[[(3R,4S)-3-fluoropiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound F[C@@H]1CNCC[C@@H]1NC=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O QHBAPJSQFSZDCL-KGLIPLIRSA-N 0.000 claims 1
- JPGGVPRJOMAOGD-BQFBZIMZSA-N 2-[3-[[(3R,4S)-3-fluoropiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound C1CNC[C@H]([C@H]1NC2=NC=C(N=N2)C3=C(C=C(C=C3)C4=CNN=C4)O)F.Cl.Cl JPGGVPRJOMAOGD-BQFBZIMZSA-N 0.000 claims 1
- QIUMREZZUPSWKC-BBRMVZONSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1,2,4-thiadiazol-5-yl)phenol Chemical compound CC1(C)C[C@H](NC2=NC=C(N=N2)C2=C(O)C=C(C=C2)C2=NC=NS2)[C@H](F)C(C)(C)N1 QIUMREZZUPSWKC-BBRMVZONSA-N 0.000 claims 1
- XBSSXUQVQUBXKT-LINSIKMZSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1,2,4-thiadiazol-5-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1(C)C[C@H](Nc2ncc(nn2)-c2ccc(cc2O)-c2ncns2)[C@H](F)C(C)(C)N1 XBSSXUQVQUBXKT-LINSIKMZSA-N 0.000 claims 1
- JIXPMXJNQZXMPW-YOEHRIQHSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1,3-oxazol-2-yl)phenol Chemical compound CC1(C)C[C@H](NC2=NC=C(N=N2)C2=C(O)C=C(C=C2)C2=NC=CO2)[C@H](F)C(C)(C)N1 JIXPMXJNQZXMPW-YOEHRIQHSA-N 0.000 claims 1
- SYKKRKXNHINNPC-RVXRQPKJSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1,3-oxazol-2-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1(C)C[C@H](Nc2ncc(nn2)-c2ccc(cc2O)-c2ncco2)[C@H](F)C(C)(C)N1 SYKKRKXNHINNPC-RVXRQPKJSA-N 0.000 claims 1
- DHDWGOCZNSBLAN-CVDCTZTESA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1-methylindazol-5-yl)phenol Chemical compound CN1N=CC2=C1C=CC(=C2)C1=CC(O)=C(C=C1)C1=CN=C(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)N=N1 DHDWGOCZNSBLAN-CVDCTZTESA-N 0.000 claims 1
- TXDNFAAYZVPJML-HXTKCBNGSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1-methylindazol-5-yl)phenol dihydrochloride Chemical compound Cl.Cl.Cn1ncc2cc(ccc12)-c1ccc(c(O)c1)-c1cnc(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)nn1 TXDNFAAYZVPJML-HXTKCBNGSA-N 0.000 claims 1
- UJXRSKVCIDPENV-LPHOPBHVSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-3-yl)phenol Chemical compound CN1C=CC(=N1)C1=CC(O)=C(C=C1)C1=CN=C(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)N=N1 UJXRSKVCIDPENV-LPHOPBHVSA-N 0.000 claims 1
- BMORGZTZLMAHFK-VBKBRSQCSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-3-yl)phenol dihydrochloride Chemical compound Cl.Cl.Cn1ccc(n1)-c1ccc(c(O)c1)-c1cnc(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)nn1 BMORGZTZLMAHFK-VBKBRSQCSA-N 0.000 claims 1
- SISBKYXCVOUUTN-LPHOPBHVSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1-methylpyrazol-4-yl)phenol Chemical compound CN1C=C(C=N1)C1=CC(O)=C(C=C1)C1=CN=C(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)N=N1 SISBKYXCVOUUTN-LPHOPBHVSA-N 0.000 claims 1
- GZOYDHQPWIGCRD-RXVVDRJESA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1-methylpyrazolo[3,4-b]pyridin-5-yl)phenol Chemical compound Cn1ncc2cc(cnc12)-c1ccc(c(O)c1)-c1cnc(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)nn1 GZOYDHQPWIGCRD-RXVVDRJESA-N 0.000 claims 1
- NFFGBAOSTIKDLK-AEOSXFHFSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1-methylpyrazolo[3,4-b]pyridin-5-yl)phenol dihydrochloride Chemical compound Cl.Cl.Cn1ncc2cc(cnc12)-c1ccc(c(O)c1)-c1cnc(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)nn1 NFFGBAOSTIKDLK-AEOSXFHFSA-N 0.000 claims 1
- JZVWLFOAZASBMO-YJBOKZPZSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CC1(C)C[C@H](NC2=NC=C(N=N2)C2=C(O)C=C(C=C2)C2=CNN=C2)[C@H](F)C(C)(C)N1 JZVWLFOAZASBMO-YJBOKZPZSA-N 0.000 claims 1
- KUPLILKPQGGSNY-BBRMVZONSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(2-methyltetrazol-5-yl)phenol Chemical compound CN1N=NC(=N1)C1=CC(O)=C(C=C1)C1=CN=C(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)N=N1 KUPLILKPQGGSNY-BBRMVZONSA-N 0.000 claims 1
- LBXOJGVOHRLYPL-LINSIKMZSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(2-methyltetrazol-5-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.Cn1nnc(n1)-c1ccc(c(O)c1)-c1cnc(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)nn1 LBXOJGVOHRLYPL-LINSIKMZSA-N 0.000 claims 1
- SXYKIQWEALXZST-KSSFIOAISA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(2-methyltriazol-4-yl)phenol Chemical compound CN1N=CC(=N1)C1=CC(O)=C(C=C1)C1=CN=C(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)N=N1 SXYKIQWEALXZST-KSSFIOAISA-N 0.000 claims 1
- DUZCTBHNIXOGDD-DJKAKHFESA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(2-methyltriazol-4-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.Cn1ncc(n1)-c1ccc(c(O)c1)-c1cnc(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)nn1 DUZCTBHNIXOGDD-DJKAKHFESA-N 0.000 claims 1
- TWWULYGKVMJXJT-GUYCJALGSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(2H-triazol-4-yl)phenol Chemical compound CC1(C)C[C@H](Nc2ncc(nn2)-c2ccc(cc2O)-c2cn[nH]n2)[C@H](F)C(C)(C)N1 TWWULYGKVMJXJT-GUYCJALGSA-N 0.000 claims 1
- LVCRMQDBYPAAJE-ZMQOMOPGSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(2H-triazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CC1(C)C[C@H](Nc2ncc(nn2)-c2ccc(cc2O)-c2cn[nH]n2)[C@H](F)C(C)(C)N1 LVCRMQDBYPAAJE-ZMQOMOPGSA-N 0.000 claims 1
- SLAMJCWXDQJVSY-LPHOPBHVSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(4-methylimidazol-1-yl)phenol Chemical compound CC1=CN(C=N1)C1=CC(O)=C(C=C1)C1=CN=C(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)N=N1 SLAMJCWXDQJVSY-LPHOPBHVSA-N 0.000 claims 1
- ODIBMQNQFIEUSU-VBKBRSQCSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(4-methylimidazol-1-yl)phenol dihydrochloride Chemical compound Cl.Cl.Cc1cn(cn1)-c1ccc(c(O)c1)-c1cnc(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)nn1 ODIBMQNQFIEUSU-VBKBRSQCSA-N 0.000 claims 1
- OLCSMVQGEFCNJY-JXFKEZNVSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(6-methoxypyrimidin-4-yl)phenol Chemical compound COC1=NC=NC(=C1)C1=CC(O)=C(C=C1)C1=CN=C(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)N=N1 OLCSMVQGEFCNJY-JXFKEZNVSA-N 0.000 claims 1
- GXQFYHORDQMJIK-XXRBRTKDSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(6-methoxypyrimidin-4-yl)phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COc1cc(ncn1)-c1ccc(c(O)c1)-c1cnc(N[C@H]2CC(C)(C)NC(C)(C)[C@H]2F)nn1 GXQFYHORDQMJIK-XXRBRTKDSA-N 0.000 claims 1
- OZKUYXIXGDLMRU-KKSFZXQISA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-imidazo[1,2-a]pyrazin-6-ylphenol Chemical compound CC1(C)C[C@H](NC2=NC=C(N=N2)C2=C(O)C=C(C=C2)C2=CN3C=CN=C3C=N2)[C@H](F)C(C)(C)N1 OZKUYXIXGDLMRU-KKSFZXQISA-N 0.000 claims 1
- OKAJZJZCAPWSMW-UWJYYQICSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-imidazo[1,2-b]pyridazin-6-ylphenol Chemical compound CC1(C)C[C@H](NC2=NC=C(N=N2)C2=C(O)C=C(C=C2)C2=NN3C=CN=C3C=C2)[C@H](F)C(C)(C)N1 OKAJZJZCAPWSMW-UWJYYQICSA-N 0.000 claims 1
- QKOJPVYFIIMSPR-BGESAIIZSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-imidazo[1,2-b]pyridazin-6-ylphenol dihydrochloride Chemical compound Cl.Cl.CC1(C)C[C@H](Nc2ncc(nn2)-c2ccc(cc2O)-c2ccc3nccn3n2)[C@H](F)C(C)(C)N1 QKOJPVYFIIMSPR-BGESAIIZSA-N 0.000 claims 1
- ZPYNSCJPVKATOY-YJBOKZPZSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-imidazol-1-ylphenol Chemical compound CC1(C)C[C@H](NC2=NC=C(N=N2)C2=C(O)C=C(C=C2)N2C=CN=C2)[C@H](F)C(C)(C)N1 ZPYNSCJPVKATOY-YJBOKZPZSA-N 0.000 claims 1
- BVEKXRYOCXTMHH-WQPBPYDNSA-N 2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-imidazol-1-ylphenol dihydrochloride Chemical compound Cl.Cl.CC1(C)C[C@H](Nc2ncc(nn2)-c2ccc(cc2O)-n2ccnc2)[C@H](F)C(C)(C)N1 BVEKXRYOCXTMHH-WQPBPYDNSA-N 0.000 claims 1
- BVUNWHBQBLTSJR-ICSRJNTNSA-N 2-[3-[[(3S,4S)-3-methoxy-2,2,6,6-tetramethylpiperidin-4-yl]-methylamino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CO[C@@H]1C(NC(C[C@@H]1N(C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O)C)(C)C)(C)C BVUNWHBQBLTSJR-ICSRJNTNSA-N 0.000 claims 1
- QVSCXUWJTLTQNF-OINVMNEBSA-N 2-[3-[[(3S,4S)-3-methoxy-2,2,6,6-tetramethylpiperidin-4-yl]-methylamino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CO[C@H]1[C@H](CC(C)(C)NC1(C)C)N(C)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 QVSCXUWJTLTQNF-OINVMNEBSA-N 0.000 claims 1
- WRYXZECRTZTICJ-LPHOPBHVSA-N 2-[3-[[(3S,4S)-3-methoxy-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CO[C@H]1[C@H](CC(C)(C)NC1(C)C)NC1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 WRYXZECRTZTICJ-LPHOPBHVSA-N 0.000 claims 1
- NJWCEQKEJXVFGH-UHFFFAOYSA-N 2-[3-[methyl(piperidin-3-yl)amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CN(C1CCCNC1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 NJWCEQKEJXVFGH-UHFFFAOYSA-N 0.000 claims 1
- XKSLBKQETONBFK-UHFFFAOYSA-N 2-[3-[methyl(piperidin-3-yl)amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CN(C1CCCNC1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 XKSLBKQETONBFK-UHFFFAOYSA-N 0.000 claims 1
- UNDVPHYYRCRWIE-UHFFFAOYSA-N 2-[3-[methyl(piperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound CN(C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NNC=1)O)C1CCNCC1 UNDVPHYYRCRWIE-UHFFFAOYSA-N 0.000 claims 1
- XIOSCSZUMRUYDZ-UHFFFAOYSA-N 2-[3-[methyl(piperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CN(C1CCNCC1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 XIOSCSZUMRUYDZ-UHFFFAOYSA-N 0.000 claims 1
- VAYDUOFABLAEKM-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-(1-methyltriazolo[4,5-b]pyridin-5-yl)phenol Chemical compound CN(C=1N=NC(=CN=1)C1=C(C=C(C=C1)C1=CC=C2C(=N1)N=NN2C)O)C1CC(NC(C1)(C)C)(C)C VAYDUOFABLAEKM-UHFFFAOYSA-N 0.000 claims 1
- ULQQYVAROGLUIK-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-(triazolo[1,5-a]pyridin-5-yl)phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC2=CN=NN2C=C1 ULQQYVAROGLUIK-UHFFFAOYSA-N 0.000 claims 1
- AHBRKMXCGQTDHW-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-(triazolo[1,5-a]pyridin-5-yl)phenol dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1ccn2nncc2c1 AHBRKMXCGQTDHW-UHFFFAOYSA-N 0.000 claims 1
- KVGVJDUCKDJLDS-VPYROQPTSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]phenol Chemical compound [2H]C([2H])([2H])N1C=C(C=N1)C1=CC(O)=C(C=C1)C1=CN=C(N=N1)N(C)C1CC(C)(C)NC(C)(C)C1 KVGVJDUCKDJLDS-VPYROQPTSA-N 0.000 claims 1
- YZGFSZQMTMLWQB-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyrazin-2-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CN=CC=N1 YZGFSZQMTMLWQB-UHFFFAOYSA-N 0.000 claims 1
- BGCMHDWUWCJULN-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyridazin-3-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cccnn1 BGCMHDWUWCJULN-UHFFFAOYSA-N 0.000 claims 1
- YQBHBOVNFQKOGV-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyridazin-4-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1ccnnc1 YQBHBOVNFQKOGV-UHFFFAOYSA-N 0.000 claims 1
- WXRBDWCCYGIMPG-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyridazin-4-ylphenol dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1ccnnc1 WXRBDWCCYGIMPG-UHFFFAOYSA-N 0.000 claims 1
- XIBNSPIDEBJNEG-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyridin-2-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NC=CC=C1 XIBNSPIDEBJNEG-UHFFFAOYSA-N 0.000 claims 1
- GINIIZKQAMMHMI-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyridin-3-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cccnc1 GINIIZKQAMMHMI-UHFFFAOYSA-N 0.000 claims 1
- YSDPIAJUGTXJMF-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyridin-4-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC=NC=C1 YSDPIAJUGTXJMF-UHFFFAOYSA-N 0.000 claims 1
- LBFONZSBFXSDAQ-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyrimidin-2-ylphenol Chemical compound CN(C=1N=NC(=CN=1)C1=C(C=C(C=C1)C1=NC=CC=N1)O)C1CC(NC(C1)(C)C)(C)C LBFONZSBFXSDAQ-UHFFFAOYSA-N 0.000 claims 1
- AXKRVBCAKOGMQV-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyrimidin-4-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC=NC=N1 AXKRVBCAKOGMQV-UHFFFAOYSA-N 0.000 claims 1
- VVMWKQKCMBYDMW-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-quinolin-6-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC=C2N=CC=CC2=C1 VVMWKQKCMBYDMW-UHFFFAOYSA-N 0.000 claims 1
- CULMDJHLYUWYET-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-quinolin-6-ylphenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1ccc2ncccc2c1 CULMDJHLYUWYET-UHFFFAOYSA-N 0.000 claims 1
- DWHWJYPRNRKTMP-UHFFFAOYSA-N 2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-thiophen-2-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC=CS1 DWHWJYPRNRKTMP-UHFFFAOYSA-N 0.000 claims 1
- NWSDGCVODQXXMR-VPYROQPTSA-N 2-[6-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]phenol Chemical compound C(N1N=CC(=C1)C=1C=CC(=C(C=1)O)C=1N=NC(=CN=1)NC1CC(NC(C1)(C)C)(C)C)([2H])([2H])[2H] NWSDGCVODQXXMR-VPYROQPTSA-N 0.000 claims 1
- XHXNJXDTNZOAPQ-UHFFFAOYSA-N 2-[6-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-3-yl]-5-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C1=CN=C(N=N1)C1=C(C=C(C=C1)C=1C=NNC=1)O XHXNJXDTNZOAPQ-UHFFFAOYSA-N 0.000 claims 1
- NHRQQMQIMOZVHV-UHFFFAOYSA-N 2-[6-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-3-yl]-5-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CC(C)(C)NC1CCN(C1)c1cnc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 NHRQQMQIMOZVHV-UHFFFAOYSA-N 0.000 claims 1
- XFRDHRYTHOVQIU-UHFFFAOYSA-N 2-[6-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-3-yl]-5-(5-fluoro-1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C1=CN=C(N=N1)C1=C(C=C(C=C1)C=1C(=NNC=1)F)O XFRDHRYTHOVQIU-UHFFFAOYSA-N 0.000 claims 1
- WLSQOKCLWNIWOH-UHFFFAOYSA-N 2-[6-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-3-yl]-5-(5-fluoro-1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CC(C)(C)NC1CCN(C1)c1cnc(nn1)-c1ccc(cc1O)-c1cn[nH]c1F WLSQOKCLWNIWOH-UHFFFAOYSA-N 0.000 claims 1
- JXRHIUDJKVASTJ-VPYROQPTSA-N 2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]-5-[1-(trideuteriomethyl)pyrazol-4-yl]phenol Chemical compound C(N1N=CC(=C1)C=1C=CC(=C(C=1)O)C=1N=NC(=CN=1)N(C1CC(NC(C1)(C)C)(C)C)C)([2H])([2H])[2H] JXRHIUDJKVASTJ-VPYROQPTSA-N 0.000 claims 1
- XCDPNDWSQOBCSM-UHFFFAOYSA-N 2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]-5-pyrazin-2-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=CN=CC=N1 XCDPNDWSQOBCSM-UHFFFAOYSA-N 0.000 claims 1
- OWLRHKMYLMFFKD-UHFFFAOYSA-N 2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]-5-pyridin-2-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=NC=CC=C1 OWLRHKMYLMFFKD-UHFFFAOYSA-N 0.000 claims 1
- CGYVWZBGCQAWTB-UHFFFAOYSA-N 2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]-5-pyridin-3-ylphenol Chemical compound C1=CC(C2=CC(=C(C=C2)C2=NC=C(N(C3CC(NC(C3)(C)C)(C)C)C)N=N2)O)=CN=C1 CGYVWZBGCQAWTB-UHFFFAOYSA-N 0.000 claims 1
- DVRGMDVMQMKIQX-UHFFFAOYSA-N 2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]-5-pyridin-4-ylphenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=CC=NC=C1 DVRGMDVMQMKIQX-UHFFFAOYSA-N 0.000 claims 1
- YJTMCKGSNUJZCX-UHFFFAOYSA-N 2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]-5-pyrimidin-2-ylphenol Chemical compound N1=CC=CN=C1C1=CC=C(C2=NC=C(N=N2)N(C2CC(NC(C)(C)C2)(C)C)C)C(O)=C1 YJTMCKGSNUJZCX-UHFFFAOYSA-N 0.000 claims 1
- OQHQOOLVQDEIGL-UHFFFAOYSA-N 2-methyl-2,7-diazaspiro[4.4]nonane Chemical compound C1N(C)CCC11CNCC1 OQHQOOLVQDEIGL-UHFFFAOYSA-N 0.000 claims 1
- SIGWPXIXDIJJOP-UHFFFAOYSA-N 3-(1-methylpyrazol-3-yl)-6-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]benzene-1,2-diol Chemical compound C1=CN(N=C1C1=CC=C(C2=CN=C(N=N2)N(C2CC(C)(NC(C2)(C)C)C)C)C(O)=C1O)C SIGWPXIXDIJJOP-UHFFFAOYSA-N 0.000 claims 1
- JPKXLIRUIIDDDA-UHFFFAOYSA-N 3-amino-6-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]-4-methyl-1H-pyridin-2-one Chemical compound NC=1C(=NC(=CC=1C)C1=CC(=C(C=C1)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C)O)O JPKXLIRUIIDDDA-UHFFFAOYSA-N 0.000 claims 1
- ZGRIZNKAVPPURY-UHFFFAOYSA-N 4-[3-hydroxy-4-[3-(7-methyl-2,7-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]phenyl]-1-methylpyridin-2-one Chemical compound OC=1C=C(C=CC=1C1=CN=C(N=N1)N1CC2(C1)CCN(CC2)C)C1=CC(N(C=C1)C)=O ZGRIZNKAVPPURY-UHFFFAOYSA-N 0.000 claims 1
- NWOJBNQPULQMLE-UHFFFAOYSA-N 4-[3-hydroxy-4-[3-(7-methyl-2,7-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]phenyl]-1-methylpyridin-2-one hydrochloride Chemical compound Cl.OC=1C=C(C=CC1C1=CN=C(N=N1)N1CC2(C1)CCN(CC2)C)C2=CC(N(C=C2)C)=O NWOJBNQPULQMLE-UHFFFAOYSA-N 0.000 claims 1
- XFAWBYKAABUOSH-UHFFFAOYSA-N 4-[3-hydroxy-4-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenyl]-1-methylpyridin-2-one Chemical compound OC=1C=C(C=CC=1C1=CN=C(N=N1)N1CC(CC1)NC(C)C)C1=CC(N(C=C1)C)=O XFAWBYKAABUOSH-UHFFFAOYSA-N 0.000 claims 1
- DGNSWWBYFTVYOX-UHFFFAOYSA-N 4-[3-hydroxy-4-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenyl]-1-methylpyridin-2-one hydrochloride Chemical compound Cl.CC(C)NC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1ccn(C)c(=O)c1 DGNSWWBYFTVYOX-UHFFFAOYSA-N 0.000 claims 1
- WBWVRECVZZJCRY-UHFFFAOYSA-N 4-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]-1-methylpyridin-2-one Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC(=O)N(C)C=C1 WBWVRECVZZJCRY-UHFFFAOYSA-N 0.000 claims 1
- VKMXNMVKZGEFRP-UHFFFAOYSA-N 4-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]-1H-pyrazole-5-carbonitrile Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=C(NN=C1)C#N VKMXNMVKZGEFRP-UHFFFAOYSA-N 0.000 claims 1
- RGLHGBQSTBWRTI-UHFFFAOYSA-N 4-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]-2-methylpyrazole-3-carbonitrile Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=C(C#N)N(C)N=C1 RGLHGBQSTBWRTI-UHFFFAOYSA-N 0.000 claims 1
- IZZPCQIUWUHWGH-UHFFFAOYSA-N 4-[3-hydroxy-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]phenyl]-1H-pyrazole-5-carbonitrile Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=C(NN=C1)C#N IZZPCQIUWUHWGH-UHFFFAOYSA-N 0.000 claims 1
- ZADSTFXIMJZXOO-UHFFFAOYSA-N 4-[3-hydroxy-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]phenyl]-2-methylpyrazole-3-carbonitrile Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=C(C#N)N(C)N=C1 ZADSTFXIMJZXOO-UHFFFAOYSA-N 0.000 claims 1
- PYMNETVRMIRSHC-UHFFFAOYSA-N 4-[4-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-3-hydroxyphenyl]-1H-pyrazole-5-carbonitrile Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C(=NNC=1)C#N)O PYMNETVRMIRSHC-UHFFFAOYSA-N 0.000 claims 1
- UQYDTJFWESHTSX-UHFFFAOYSA-N 4-[4-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-3-hydroxyphenyl]-1H-pyrazole-5-carbonitrile dihydrochloride Chemical compound Cl.Cl.C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN1)C1=C(C=C(C=C1)C=1C(=NNC1)C#N)O UQYDTJFWESHTSX-UHFFFAOYSA-N 0.000 claims 1
- RREFRGLVXSRGLE-UHFFFAOYSA-N 5-(1,3-benzodioxol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC2=C(OCO2)C=C1 RREFRGLVXSRGLE-UHFFFAOYSA-N 0.000 claims 1
- LYDMBAWOQAVEDT-UHFFFAOYSA-N 5-(1,3-oxazol-2-yl)-2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound O1C(=NC=C1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N1CC(CC1)NC(C)C LYDMBAWOQAVEDT-UHFFFAOYSA-N 0.000 claims 1
- AINAFLFPIKGSCC-UHFFFAOYSA-N 5-(1,5-dimethylpyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN1N=CC(=C1C)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C AINAFLFPIKGSCC-UHFFFAOYSA-N 0.000 claims 1
- FYWUSPASBJRTDH-UHFFFAOYSA-N 5-(1,5-dimethylpyrazol-4-yl)-2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]phenol Chemical compound CN1N=CC(=C1C)C=1C=CC(=C(C=1)O)C=1N=NC(=CN=1)N(C1CC(NC(C1)(C)C)(C)C)C FYWUSPASBJRTDH-UHFFFAOYSA-N 0.000 claims 1
- XNBUGIJGMHRKLR-UHFFFAOYSA-N 5-(1-cyclopropylpyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CN(N=C1)C1CC1 XNBUGIJGMHRKLR-UHFFFAOYSA-N 0.000 claims 1
- QIEFGFAMKVXAMT-UHFFFAOYSA-N 5-(1-cyclopropylpyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cnn(c1)C1CC1 QIEFGFAMKVXAMT-UHFFFAOYSA-N 0.000 claims 1
- FVYFFAPOWGRBPY-UHFFFAOYSA-N 5-(1-methylbenzimidazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC=C2N(C)C=NC2=C1 FVYFFAPOWGRBPY-UHFFFAOYSA-N 0.000 claims 1
- PYWGUVLZNSNLTO-UHFFFAOYSA-N 5-(1-methylbenzotriazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC=C2N(C)N=NC2=C1 PYWGUVLZNSNLTO-UHFFFAOYSA-N 0.000 claims 1
- NWSAMQQOLQCUJP-UHFFFAOYSA-N 5-(1-methylimidazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CN(C)C=N1 NWSAMQQOLQCUJP-UHFFFAOYSA-N 0.000 claims 1
- RITBTHZJBQZWAR-UHFFFAOYSA-N 5-(1-methylimidazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN1C=NC(=C1)C=1C=CC(=C(C1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C RITBTHZJBQZWAR-UHFFFAOYSA-N 0.000 claims 1
- QSGCFAJPAIASSU-UHFFFAOYSA-N 5-(1-methylindazol-5-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound N1(C)C2=CC=C(C3=CC=C(C4=CN=C(N=N4)NC4CC(NC(C4)(C)C)(C)C)C(O)=C3)C=C2C=N1 QSGCFAJPAIASSU-UHFFFAOYSA-N 0.000 claims 1
- RCEDBSJKNMNSON-UHFFFAOYSA-N 5-(1-methylindazol-5-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol trihydrochloride Chemical compound Cl.Cl.Cl.CN1N=CC2=CC(=CC=C12)C=1C=CC(=C(C1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C RCEDBSJKNMNSON-UHFFFAOYSA-N 0.000 claims 1
- WEDCLXPEYKMDLQ-UHFFFAOYSA-N 5-(1-methylindazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC2=C(C=C1)N(C)N=C2 WEDCLXPEYKMDLQ-UHFFFAOYSA-N 0.000 claims 1
- OWDHUIORMYURHT-UHFFFAOYSA-N 5-(1-methylpyrazol-3-yl)-2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxy-1,2,4-triazin-6-yl]phenol Chemical compound CN1N=C(C=C1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)OC1CC(NC(C1)(C)C)(C)C OWDHUIORMYURHT-UHFFFAOYSA-N 0.000 claims 1
- UHCPNQLAGZAGSA-UHFFFAOYSA-N 5-(1-methylpyrazol-3-yl)-2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxy-1,2,4-triazin-6-yl]phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.Cn1ccc(n1)-c1ccc(c(O)c1)-c1cnc(OC2CC(C)(C)NC(C)(C)C2)nn1 UHCPNQLAGZAGSA-UHFFFAOYSA-N 0.000 claims 1
- BZBMRMFUSXOJFZ-UHFFFAOYSA-N 5-(1-methylpyrazol-3-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN1N=C(C=C1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C BZBMRMFUSXOJFZ-UHFFFAOYSA-N 0.000 claims 1
- VKUASDMPTSARJE-UHFFFAOYSA-N 5-(1-methylpyrazol-3-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NN(C)C=C1 VKUASDMPTSARJE-UHFFFAOYSA-N 0.000 claims 1
- LGBYUCPYBCPVMO-UHFFFAOYSA-N 5-(1-methylpyrazol-3-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN1N=C(C=C1)C=1C=CC(=C(C1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C LGBYUCPYBCPVMO-UHFFFAOYSA-N 0.000 claims 1
- TWAQQEOIIQZKOT-UHFFFAOYSA-N 5-(1-methylpyrazol-4-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C TWAQQEOIIQZKOT-UHFFFAOYSA-N 0.000 claims 1
- KVGVJDUCKDJLDS-UHFFFAOYSA-N 5-(1-methylpyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NN(C=1)C)O)C1CC(NC(C1)(C)C)(C)C KVGVJDUCKDJLDS-UHFFFAOYSA-N 0.000 claims 1
- YISQCEKJTWVFTL-UHFFFAOYSA-N 5-(1-methylpyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cnn(C)c1 YISQCEKJTWVFTL-UHFFFAOYSA-N 0.000 claims 1
- KOPGWTHDJUUGCP-UHFFFAOYSA-N 5-(1-methylpyrazolo[3,4-b]pyridin-5-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound Cn1ncc2cc(cnc12)-c1ccc(c(O)c1)-c1cnc(NC2CC(C)(C)NC(C)(C)C2)nn1 KOPGWTHDJUUGCP-UHFFFAOYSA-N 0.000 claims 1
- XYADFKNQKXLYJI-UHFFFAOYSA-N 5-(1-methylpyrazolo[3,4-b]pyridin-5-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol trihydrochloride Chemical compound Cl.Cl.Cl.CN1N=CC=2C1=NC=C(C2)C=2C=CC(=C(C2)O)C2=CN=C(N=N2)NC2CC(NC(C2)(C)C)(C)C XYADFKNQKXLYJI-UHFFFAOYSA-N 0.000 claims 1
- ZKYKVESLUGXALS-UHFFFAOYSA-N 5-(1-methylpyrazolo[3,4-b]pyridin-5-yl)-2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound CN1N=CC=2C1=NC=C(C=2)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N1CC(CC1)NC(C)C ZKYKVESLUGXALS-UHFFFAOYSA-N 0.000 claims 1
- GCBJHNMZASCIMR-UHFFFAOYSA-N 5-(1-methylpyrazolo[3,4-b]pyridin-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC2=C(N=C1)N(C)N=C2 GCBJHNMZASCIMR-UHFFFAOYSA-N 0.000 claims 1
- RDFCGXQDFGNOIB-UHFFFAOYSA-N 5-(1-methylpyrazolo[3,4-c]pyridin-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cc2cnn(C)c2cn1 RDFCGXQDFGNOIB-UHFFFAOYSA-N 0.000 claims 1
- IOANDIWFHWUYPS-UHFFFAOYSA-N 5-(1-methylpyrazolo[3,4-c]pyridin-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cc2cnn(C)c2cn1 IOANDIWFHWUYPS-UHFFFAOYSA-N 0.000 claims 1
- VNYDSVJCHGEVKM-UHFFFAOYSA-N 5-(1-methylpyrazolo[4,3-b]pyridin-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NC2=C(C=C1)N(C)N=C2 VNYDSVJCHGEVKM-UHFFFAOYSA-N 0.000 claims 1
- PZODBDHTCASPNJ-UHFFFAOYSA-N 5-(1-methylpyrazolo[4,3-b]pyridin-5-yl)-2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=NC2=C(C=C1)N(C)N=C2 PZODBDHTCASPNJ-UHFFFAOYSA-N 0.000 claims 1
- UKMDNYKYGQOWTF-UHFFFAOYSA-N 5-(1-methylpyrazolo[4,3-d]pyrimidin-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NC=C2N(C)N=CC2=N1 UKMDNYKYGQOWTF-UHFFFAOYSA-N 0.000 claims 1
- JXSYPDIECVPSTG-UHFFFAOYSA-N 5-(1H-indazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound N1N=CC2=CC(=CC=C12)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C JXSYPDIECVPSTG-UHFFFAOYSA-N 0.000 claims 1
- HFECLPRIOXNRNS-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxy-1,2,4-triazin-6-yl]phenol Chemical compound CC1(C)CC(CC(C)(C)N1)OC1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 HFECLPRIOXNRNS-UHFFFAOYSA-N 0.000 claims 1
- OQGNOCJYOHGFNV-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-2-[3-(3,3,5,5-tetramethylpiperazin-1-yl)-1,2,4-triazin-6-yl]phenol Chemical compound CC1(C)CN(CC(C)(C)N1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 OQGNOCJYOHGFNV-UHFFFAOYSA-N 0.000 claims 1
- JZAITWRATWVIFL-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-2-[3-(3,3,5,5-tetramethylpiperazin-1-yl)-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.CC1(C)CN(CC(C)(C)N1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1 JZAITWRATWVIFL-UHFFFAOYSA-N 0.000 claims 1
- LONKDCLAOQMQKK-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CC1(C)CC(CC(C)(C)N1)NC1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 LONKDCLAOQMQKK-UHFFFAOYSA-N 0.000 claims 1
- RAZXPXHGADZSCV-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-2-[3-[3-[(pyridin-2-ylmethylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound N1N=CC(C2=CC(=C(C3=CN=C(N=N3)N3CCC(CNCC4=NC=CC=C4)C3)C=C2)O)=C1 RAZXPXHGADZSCV-UHFFFAOYSA-N 0.000 claims 1
- QFFSOERAWOFABA-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxy-1,2,4-triazin-3-yl]phenol Chemical compound CC1(C)CC(CC(C)(C)N1)OC1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 QFFSOERAWOFABA-UHFFFAOYSA-N 0.000 claims 1
- DBELCLNDDRXBHQ-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-2-[6-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]phenol Chemical compound CC1(C)CC(CC(C)(C)N1)NC1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1 DBELCLNDDRXBHQ-UHFFFAOYSA-N 0.000 claims 1
- AUZUCBFOGZIHQQ-UHFFFAOYSA-N 5-(1H-pyrazol-5-yl)-2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxy-1,2,4-triazin-6-yl]phenol Chemical compound CC1(C)CC(CC(C)(C)N1)OC1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NNC=C1 AUZUCBFOGZIHQQ-UHFFFAOYSA-N 0.000 claims 1
- OUGRYZLTFNOXEE-UHFFFAOYSA-N 5-(2-methyl-1,3-oxazol-5-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CC1=NC=C(O1)C1=CC(O)=C(C=C1)C1=CN=C(NC2CC(C)(C)NC(C)(C)C2)N=N1 OUGRYZLTFNOXEE-UHFFFAOYSA-N 0.000 claims 1
- XJTTVGHBZUWSEZ-UHFFFAOYSA-N 5-(2-methyl-1,3-oxazol-5-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.Cc1ncc(o1)-c1ccc(c(O)c1)-c1cnc(NC2CC(C)(C)NC(C)(C)C2)nn1 XJTTVGHBZUWSEZ-UHFFFAOYSA-N 0.000 claims 1
- RXWFDHXVZVKJKP-UHFFFAOYSA-N 5-(2-methyl-1,3-oxazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CN=C(C)O1 RXWFDHXVZVKJKP-UHFFFAOYSA-N 0.000 claims 1
- QBEKKYQSXLXMGB-UHFFFAOYSA-N 5-(2-methyl-1,3-oxazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CC=1OC(=CN1)C=1C=CC(=C(C1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C QBEKKYQSXLXMGB-UHFFFAOYSA-N 0.000 claims 1
- DQMCWLDVWBFLQI-UHFFFAOYSA-N 5-(2-methylpyrazol-3-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC=NN1C DQMCWLDVWBFLQI-UHFFFAOYSA-N 0.000 claims 1
- QLHLAQFDYXMAAC-UHFFFAOYSA-N 5-(2-methyltetrazol-5-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN1N=C(N=N1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C QLHLAQFDYXMAAC-UHFFFAOYSA-N 0.000 claims 1
- ZTGQZNMUAVGTCD-UHFFFAOYSA-N 5-(2-methyltetrazol-5-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.Cn1nnc(n1)-c1ccc(c(O)c1)-c1cnc(NC2CC(C)(C)NC(C)(C)C2)nn1 ZTGQZNMUAVGTCD-UHFFFAOYSA-N 0.000 claims 1
- QWNZEVFFIJLKQE-UHFFFAOYSA-N 5-(2-methyltriazol-4-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN1N=CC(=N1)C1=CC(O)=C(C=C1)C1=CN=C(NC2CC(C)(C)NC(C)(C)C2)N=N1 QWNZEVFFIJLKQE-UHFFFAOYSA-N 0.000 claims 1
- HJNRMEFXXPTVTF-UHFFFAOYSA-N 5-(2-methyltriazol-4-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.Cn1ncc(n1)-c1ccc(c(O)c1)-c1cnc(NC2CC(C)(C)NC(C)(C)C2)nn1 HJNRMEFXXPTVTF-UHFFFAOYSA-N 0.000 claims 1
- VFONSPSHIKJVMO-UHFFFAOYSA-N 5-(2-methyltriazol-4-yl)-2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound CC(C)NC1CCN(C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NN(C)N=C1 VFONSPSHIKJVMO-UHFFFAOYSA-N 0.000 claims 1
- QAIICINLVPHWQM-UHFFFAOYSA-N 5-(3-chloro-1,2,4-triazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=NC(Cl)=N1 QAIICINLVPHWQM-UHFFFAOYSA-N 0.000 claims 1
- SBKNRXCQYIAXTH-UHFFFAOYSA-N 5-(3-chloro-1,2,4-triazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-n1cnc(Cl)n1 SBKNRXCQYIAXTH-UHFFFAOYSA-N 0.000 claims 1
- CVYMVJNLDCIBJV-UHFFFAOYSA-N 5-(3-fluoro-1-methylpyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CN(C)N=C1F CVYMVJNLDCIBJV-UHFFFAOYSA-N 0.000 claims 1
- CONYOAOGYGYUPE-UHFFFAOYSA-N 5-(3-fluoro-1-methylpyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn(C)nc1F CONYOAOGYGYUPE-UHFFFAOYSA-N 0.000 claims 1
- ICSPSTOGVQEFBD-UHFFFAOYSA-N 5-(4-amino-1,3,5-triazin-2-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NC=NC(N)=N1 ICSPSTOGVQEFBD-UHFFFAOYSA-N 0.000 claims 1
- OAPPNARHHIULGH-UHFFFAOYSA-N 5-(4-amino-1,3,5-triazin-2-yl)-2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=NC=NC(N)=N1 OAPPNARHHIULGH-UHFFFAOYSA-N 0.000 claims 1
- KUJSLZIVPGTANN-UHFFFAOYSA-N 5-(4-chloro-1,3,5-triazin-2-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NC=NC(Cl)=N1 KUJSLZIVPGTANN-UHFFFAOYSA-N 0.000 claims 1
- ZGGYPOPKLNCFOS-UHFFFAOYSA-N 5-(4-chloro-1,3,5-triazin-2-yl)-2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=CN=C(N=N1)C1=C(O)C=C(C=C1)C1=NC=NC(Cl)=N1 ZGGYPOPKLNCFOS-UHFFFAOYSA-N 0.000 claims 1
- MJFHMLGMONSLOV-UHFFFAOYSA-N 5-(4-chloroimidazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=NC(Cl)=C1 MJFHMLGMONSLOV-UHFFFAOYSA-N 0.000 claims 1
- IDMNIAMGOXRJKT-UHFFFAOYSA-N 5-(4-chloroimidazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-n1cnc(Cl)c1 IDMNIAMGOXRJKT-UHFFFAOYSA-N 0.000 claims 1
- XHZLSIKIYNBXNY-UHFFFAOYSA-N 5-(4-fluoro-1H-pyrazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NNC=C1F XHZLSIKIYNBXNY-UHFFFAOYSA-N 0.000 claims 1
- DFNYCQKTQOUKCW-UHFFFAOYSA-N 5-(4-fluoro-1H-pyrazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1[nH]ncc1F DFNYCQKTQOUKCW-UHFFFAOYSA-N 0.000 claims 1
- DVMHPVZPRDEZSP-UHFFFAOYSA-N 5-(4-fluoroimidazol-1-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound FC=1N=CN(C=1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C DVMHPVZPRDEZSP-UHFFFAOYSA-N 0.000 claims 1
- GTHJUUJHWQYZBS-UHFFFAOYSA-N 5-(4-fluoroimidazol-1-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CC1(C)CC(CC(C)(C)N1)Nc1ncc(nn1)-c1ccc(cc1O)-n1cnc(F)c1 GTHJUUJHWQYZBS-UHFFFAOYSA-N 0.000 claims 1
- OZNJTPRZNRPEMV-KSSFIOAISA-N 5-(4-fluoroimidazol-1-yl)-2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]phenol Chemical compound FC=1N=CN(C=1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N[C@@H]1[C@@H](C(NC(C1)(C)C)(C)C)F OZNJTPRZNRPEMV-KSSFIOAISA-N 0.000 claims 1
- RFKJOWCWNCVLCL-MPWAUAJRSA-N 5-(4-fluoroimidazol-1-yl)-2-[3-[[(3S,4S)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.CC1(C)C[C@H](Nc2ncc(nn2)-c2ccc(cc2O)-n2cnc(F)c2)[C@H](F)C(C)(C)N1 RFKJOWCWNCVLCL-MPWAUAJRSA-N 0.000 claims 1
- OWKBKBQNNBTTPP-UHFFFAOYSA-N 5-(4-fluoroimidazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound FC=1N=CN(C=1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C OWKBKBQNNBTTPP-UHFFFAOYSA-N 0.000 claims 1
- HICJHANDOSFYOC-UHFFFAOYSA-N 5-(4-fluoropyrazol-1-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound FC=1C=NN(C=1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C HICJHANDOSFYOC-UHFFFAOYSA-N 0.000 claims 1
- KJKFAAZHCGXWBW-UHFFFAOYSA-N 5-(4-fluoropyrazol-1-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CC1(C)CC(CC(C)(C)N1)Nc1ncc(nn1)-c1ccc(cc1O)-n1cc(F)cn1 KJKFAAZHCGXWBW-UHFFFAOYSA-N 0.000 claims 1
- CYCJBSUSPOHCLB-UHFFFAOYSA-N 5-(4-fluoropyrazol-1-yl)-2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound N1(C=C(C=N1)F)C1=CC(=C(C2=CN=C(N=N2)N2CCC(NC)C2)C=C1)O CYCJBSUSPOHCLB-UHFFFAOYSA-N 0.000 claims 1
- NTSVRCHDZPBBIV-UHFFFAOYSA-N 5-(4-fluoropyrazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=C(F)C=N1 NTSVRCHDZPBBIV-UHFFFAOYSA-N 0.000 claims 1
- IORNFOOBITUOPN-UHFFFAOYSA-N 5-(4-hydroxyphenyl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound C1=C(O)C=CC(C2=CC=C(C3=CN=C(N(C4CC(NC(C4)(C)C)(C)C)C)N=N3)C(O)=C2)=C1 IORNFOOBITUOPN-UHFFFAOYSA-N 0.000 claims 1
- SQLFYAATUWAKGQ-UHFFFAOYSA-N 5-(4-methoxy-1,3,5-triazin-2-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound COC1=NC(=NC=N1)C1=CC(O)=C(C=C1)C1=CN=C(N=N1)N(C)C1CC(C)(C)NC(C)(C)C1 SQLFYAATUWAKGQ-UHFFFAOYSA-N 0.000 claims 1
- LVUXUTNNBVZJLP-UHFFFAOYSA-N 5-(4-methoxy-1,3,5-triazin-2-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.COc1ncnc(n1)-c1ccc(c(O)c1)-c1cnc(nn1)N(C)C1CC(C)(C)NC(C)(C)C1 LVUXUTNNBVZJLP-UHFFFAOYSA-N 0.000 claims 1
- JIAOFCIZGSRWKW-UHFFFAOYSA-N 5-(4-methoxypyrazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound COC1=CN(N=C1)C1=CC(O)=C(C=C1)C1=CN=C(N=N1)N(C)C1CC(C)(C)NC(C)(C)C1 JIAOFCIZGSRWKW-UHFFFAOYSA-N 0.000 claims 1
- MTJVFPDMVGIDDN-UHFFFAOYSA-N 5-(4-methoxypyrazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.COc1cnn(c1)-c1ccc(c(O)c1)-c1cnc(nn1)N(C)C1CC(C)(C)NC(C)(C)C1 MTJVFPDMVGIDDN-UHFFFAOYSA-N 0.000 claims 1
- BWBRVESCPFWGKL-UHFFFAOYSA-N 5-(4-methylimidazol-1-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CC=1N=CN(C=1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C BWBRVESCPFWGKL-UHFFFAOYSA-N 0.000 claims 1
- UACCBJAQZMATFE-UHFFFAOYSA-N 5-(4-methylimidazol-1-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.Cc1cn(cn1)-c1ccc(c(O)c1)-c1cnc(NC2CC(C)(C)NC(C)(C)C2)nn1 UACCBJAQZMATFE-UHFFFAOYSA-N 0.000 claims 1
- COZJSVDADCOFIN-UHFFFAOYSA-N 5-(4-methylimidazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=NC(C)=C1 COZJSVDADCOFIN-UHFFFAOYSA-N 0.000 claims 1
- KOZPMHVSRYHAFQ-UHFFFAOYSA-N 5-(4-methylimidazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-n1cnc(C)c1 KOZPMHVSRYHAFQ-UHFFFAOYSA-N 0.000 claims 1
- KLLRHQRCCASKOY-UHFFFAOYSA-N 5-(4-methylpyrazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=C(C)C=N1 KLLRHQRCCASKOY-UHFFFAOYSA-N 0.000 claims 1
- CECJZUBKOQCQCI-UHFFFAOYSA-N 5-(4-methylpyrazol-1-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-n1cc(C)cn1 CECJZUBKOQCQCI-UHFFFAOYSA-N 0.000 claims 1
- BPJAOVANZXYYDX-UHFFFAOYSA-N 5-(5-chloro-1-methylpyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound ClC1=C(C=NN1C)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C BPJAOVANZXYYDX-UHFFFAOYSA-N 0.000 claims 1
- WRQAXDOUCRXENC-UHFFFAOYSA-N 5-(5-chloro-1-methylpyrazol-4-yl)-2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]phenol Chemical compound ClC1=C(C=NN1C)C=1C=CC(=C(C=1)O)C=1N=NC(=CN=1)N(C1CC(NC(C1)(C)C)(C)C)C WRQAXDOUCRXENC-UHFFFAOYSA-N 0.000 claims 1
- IFDGDBRUVSEZSB-UHFFFAOYSA-N 5-(5-chloro-1H-pyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1Cl IFDGDBRUVSEZSB-UHFFFAOYSA-N 0.000 claims 1
- GTAAQEOIQQKZCI-UHFFFAOYSA-N 5-(5-fluoro-1H-pyrazol-4-yl)-2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxy-1,2,4-triazin-6-yl]phenol Chemical compound FC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)OC1CC(NC(C1)(C)C)(C)C GTAAQEOIQQKZCI-UHFFFAOYSA-N 0.000 claims 1
- RKRVHTMUCCNUCB-UHFFFAOYSA-N 5-(5-fluoro-1H-pyrazol-4-yl)-2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxy-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound Cl.Cl.CC1(C)CC(CC(C)(C)N1)Oc1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1F RKRVHTMUCCNUCB-UHFFFAOYSA-N 0.000 claims 1
- LTIPJLZSKIWEAC-UHFFFAOYSA-N 5-(5-fluoro-1H-pyrazol-4-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound FC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C LTIPJLZSKIWEAC-UHFFFAOYSA-N 0.000 claims 1
- NINQKVAQNCASTO-UHFFFAOYSA-N 5-(5-fluoro-1H-pyrazol-4-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol trihydrochloride Chemical compound Cl.Cl.Cl.FC1=NNC=C1C=1C=CC(=C(C1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C NINQKVAQNCASTO-UHFFFAOYSA-N 0.000 claims 1
- CJGBRMPGANBSSO-RHSMWYFYSA-N 5-(5-fluoro-1H-pyrazol-4-yl)-2-[3-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]phenol Chemical compound FC1=NNC=C1C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N[C@H]1[C@H](C(NC(C1)(C)C)(C)C)F CJGBRMPGANBSSO-RHSMWYFYSA-N 0.000 claims 1
- AMFVFTFBHXSPGJ-LVVRIOTCSA-N 5-(5-fluoro-1H-pyrazol-4-yl)-2-[3-[[(3R,4R)-3-fluoro-2,2,6,6-tetramethylpiperidin-4-yl]amino]-1,2,4-triazin-6-yl]phenol dihydrochloride Chemical compound CC1(C[C@H]([C@H](C(N1)(C)C)F)NC2=NC=C(N=N2)C3=C(C=C(C=C3)C4=C(NN=C4)F)O)C.Cl.Cl AMFVFTFBHXSPGJ-LVVRIOTCSA-N 0.000 claims 1
- PVJBITGLCVUAHK-UHFFFAOYSA-N 5-(5-fluoro-1H-pyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1F PVJBITGLCVUAHK-UHFFFAOYSA-N 0.000 claims 1
- OACYBEAMOXUWHE-UHFFFAOYSA-N 5-(5-fluoro-1H-pyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn[nH]c1F OACYBEAMOXUWHE-UHFFFAOYSA-N 0.000 claims 1
- RBZNOFWDCQAHRP-UHFFFAOYSA-N 5-(5-fluoro-1H-pyrazol-4-yl)-2-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-3-yl]phenol hydrochloride Chemical compound Cl.FC1=C(C=NN1)C=1C=CC(=C(C1)O)C=1N=NC(=CN1)N(C1CC(NC(C1)(C)C)(C)C)C RBZNOFWDCQAHRP-UHFFFAOYSA-N 0.000 claims 1
- BANGXLYLTIKQAS-UHFFFAOYSA-N 5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NN=C(C)O1 BANGXLYLTIKQAS-UHFFFAOYSA-N 0.000 claims 1
- DPBAUFGIYSSJQS-UHFFFAOYSA-N 5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1nnc(C)o1 DPBAUFGIYSSJQS-UHFFFAOYSA-N 0.000 claims 1
- ZRHPAVYYSCYQIF-UHFFFAOYSA-N 5-(5-methyl-1,3-oxazol-2-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NC=C(C)O1 ZRHPAVYYSCYQIF-UHFFFAOYSA-N 0.000 claims 1
- USSYFXGEVSGBCU-UHFFFAOYSA-N 5-(5-methyl-1,3-oxazol-2-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrobromide Chemical compound Br.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1ncc(C)o1 USSYFXGEVSGBCU-UHFFFAOYSA-N 0.000 claims 1
- NJMHMOSITDQSKC-UHFFFAOYSA-N 5-(5-methyl-1H-pyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CNN=C1C NJMHMOSITDQSKC-UHFFFAOYSA-N 0.000 claims 1
- YOSSMHZDEPCDDO-UHFFFAOYSA-N 5-(6,7-difluoro-1-methylbenzimidazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=C(F)C(F)=C2N(C)C=NC2=C1 YOSSMHZDEPCDDO-UHFFFAOYSA-N 0.000 claims 1
- DHMNJNOFSWVDLW-UHFFFAOYSA-N 5-(6,7-difluoro-3H-benzimidazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=C(F)C(F)=C2NC=NC2=C1 DHMNJNOFSWVDLW-UHFFFAOYSA-N 0.000 claims 1
- ZRMSWDDIYSRGLZ-UHFFFAOYSA-N 5-(6-methoxy-1,2,4-triazin-3-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound COC1=CN=C(N=N1)C1=CC(O)=C(C=C1)C1=CN=C(N=N1)N(C)C1CC(C)(C)NC(C)(C)C1 ZRMSWDDIYSRGLZ-UHFFFAOYSA-N 0.000 claims 1
- IYHHJTLXNDEUHD-UHFFFAOYSA-N 5-(6-methoxypyrimidin-4-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound COC1=CC(=NC=N1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C IYHHJTLXNDEUHD-UHFFFAOYSA-N 0.000 claims 1
- DUYWVNZGMLTBGI-UHFFFAOYSA-N 5-(6-methoxypyrimidin-4-yl)-2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound CNC1CCN(C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC(OC)=NC=N1 DUYWVNZGMLTBGI-UHFFFAOYSA-N 0.000 claims 1
- OWQWNVPSSIAMAV-UHFFFAOYSA-N 5-(6-methoxypyrimidin-4-yl)-2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound COC1=CC(=NC=N1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N1CC(CC1)NC(C)C OWQWNVPSSIAMAV-UHFFFAOYSA-N 0.000 claims 1
- GUIZLELWLHMLNI-UHFFFAOYSA-N 5-(7-fluoro-1-methylbenzimidazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC(F)=C2N(C)C=NC2=C1 GUIZLELWLHMLNI-UHFFFAOYSA-N 0.000 claims 1
- TZUNAXSVLAJPAL-UHFFFAOYSA-N 5-(7-fluoro-1H-indazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound FC=1C=C(C=C2C=NNC=12)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C TZUNAXSVLAJPAL-UHFFFAOYSA-N 0.000 claims 1
- XQCRGNBTUAURSO-UHFFFAOYSA-N 5-(7-fluoro-3H-benzimidazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound C1=NC2=C(N1)C(F)=CC(C1=CC=C(C3=CN=C(N=N3)N(C3CC(NC(C)(C)C3)(C)C)C)C(O)=C1)=C2 XQCRGNBTUAURSO-UHFFFAOYSA-N 0.000 claims 1
- WNOKGVLUXBYLMF-UHFFFAOYSA-N 5-(pyridin-3-ylamino)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CC1(C)CC(CC(C)(C)N1)Nc1ncc(nn1)-c1ccc(Nc2cccnc2)cc1O WNOKGVLUXBYLMF-UHFFFAOYSA-N 0.000 claims 1
- XZNGBNGLUUFPJI-UHFFFAOYSA-N 5-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]-1H-pyridin-2-one Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1ccc(=O)[nH]c1 XZNGBNGLUUFPJI-UHFFFAOYSA-N 0.000 claims 1
- IUVSLLWTSRRGRM-UHFFFAOYSA-N 5-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]-2-methylpyridazin-3-one Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC(=O)N(C)N=C1 IUVSLLWTSRRGRM-UHFFFAOYSA-N 0.000 claims 1
- MRISHWOQUJBXPE-UHFFFAOYSA-N 5-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]-2-methylpyridazin-3-one dihydrochloride Chemical compound Cl.Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cnn(C)c(=O)c1 MRISHWOQUJBXPE-UHFFFAOYSA-N 0.000 claims 1
- WAKQNUMKMPUXSL-UHFFFAOYSA-N 5-[4-(hydroxymethyl)pyrazol-1-yl]-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1C=C(CO)C=N1 WAKQNUMKMPUXSL-UHFFFAOYSA-N 0.000 claims 1
- MVJHGUYINUXHEH-UHFFFAOYSA-N 5-[4-(hydroxymethyl)triazol-2-yl]-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)N1N=CC(CO)=N1 MVJHGUYINUXHEH-UHFFFAOYSA-N 0.000 claims 1
- HLNSYZSHXJLJOL-UHFFFAOYSA-N 5-[6-(hydroxymethyl)pyrimidin-4-yl]-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC(CO)=NC=N1 HLNSYZSHXJLJOL-UHFFFAOYSA-N 0.000 claims 1
- ZXBKFPFIHHYDOQ-UHFFFAOYSA-N 5-[6-(hydroxymethyl)pyrimidin-4-yl]-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cc(CO)ncn1 ZXBKFPFIHHYDOQ-UHFFFAOYSA-N 0.000 claims 1
- RGNNIWCWAFZQSV-UHFFFAOYSA-N 5-[6-(methylamino)pyrimidin-4-yl]-2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound CNC1CCN(C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC(NC)=NC=N1 RGNNIWCWAFZQSV-UHFFFAOYSA-N 0.000 claims 1
- ILODMWDHRYEQGA-UHFFFAOYSA-N 5-imidazo[1,2-a]pyrazin-2-yl-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CC1(C)CC(CC(C)(C)N1)Nc1ncc(nn1)-c1ccc(cc1O)-c1cn2ccncc2n1 ILODMWDHRYEQGA-UHFFFAOYSA-N 0.000 claims 1
- CVBWMTGFNAVJDE-UHFFFAOYSA-N 5-imidazo[1,2-a]pyrazin-2-yl-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CC1(C)CC(CC(C)(C)N1)Nc1ncc(nn1)-c1ccc(cc1O)-c1cn2ccncc2n1 CVBWMTGFNAVJDE-UHFFFAOYSA-N 0.000 claims 1
- ZDZPXTCCPKSJIG-UHFFFAOYSA-N 5-imidazo[1,2-a]pyrazin-6-yl-2-[3-(7-methyl-2,7-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]phenol Chemical compound CN1CCC2(CN(C2)C2=NC=C(N=N2)C2=C(O)C=C(C=C2)C2=CN3C=CN=C3C=N2)CC1 ZDZPXTCCPKSJIG-UHFFFAOYSA-N 0.000 claims 1
- BTNOLGIMXVAOTR-UHFFFAOYSA-N 5-imidazo[1,2-a]pyrazin-6-yl-2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound CC(C)NC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn2ccnc2cn1 BTNOLGIMXVAOTR-UHFFFAOYSA-N 0.000 claims 1
- PCHAIVPEUXLAGH-UHFFFAOYSA-N 5-imidazo[1,2-a]pyrazin-6-yl-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CN2C=CN=C2C=N1 PCHAIVPEUXLAGH-UHFFFAOYSA-N 0.000 claims 1
- MTVBIJOSLVRSLA-UHFFFAOYSA-N 5-imidazo[1,2-a]pyrazin-6-yl-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1cn2ccnc2cn1 MTVBIJOSLVRSLA-UHFFFAOYSA-N 0.000 claims 1
- CNSLUAQDCUKVLR-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-2-yl-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound N=1C(=CN2C=1C=CC=C2)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C CNSLUAQDCUKVLR-UHFFFAOYSA-N 0.000 claims 1
- SWYLGHLDSSHASJ-UHFFFAOYSA-N 5-imidazo[1,2-b]pyridazin-6-yl-2-[3-(7-methyl-2,7-diazaspiro[3.5]nonan-2-yl)-1,2,4-triazin-6-yl]phenol Chemical compound CN1CCC2(CN(C2)C2=NC=C(N=N2)C2=C(O)C=C(C=C2)C2=NN3C=CN=C3C=C2)CC1 SWYLGHLDSSHASJ-UHFFFAOYSA-N 0.000 claims 1
- XURCZDBLZACCEP-UHFFFAOYSA-N 5-imidazo[1,2-b]pyridazin-6-yl-2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound CC(C)NC1CCN(C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NN2C=CN=C2C=C1 XURCZDBLZACCEP-UHFFFAOYSA-N 0.000 claims 1
- PGXRBNLYAQGZEJ-UHFFFAOYSA-N 5-imidazo[1,2-b]pyridazin-6-yl-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NN2C=CN=C2C=C1 PGXRBNLYAQGZEJ-UHFFFAOYSA-N 0.000 claims 1
- VBCYKOGGCNGOTA-UHFFFAOYSA-N 5-imidazo[1,2-b]pyridazin-6-yl-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.CN(C1CC(C)(C)NC(C)(C)C1)c1ncc(nn1)-c1ccc(cc1O)-c1ccc2nccn2n1 VBCYKOGGCNGOTA-UHFFFAOYSA-N 0.000 claims 1
- AHICVBUHIZBMEN-UHFFFAOYSA-N 5-imidazol-1-yl-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound N1(C=NC=C1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C AHICVBUHIZBMEN-UHFFFAOYSA-N 0.000 claims 1
- IPRZJUJOLPIROC-UHFFFAOYSA-N 5-imidazol-1-yl-2-[3-[3-(methylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound CNC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-n1ccnc1 IPRZJUJOLPIROC-UHFFFAOYSA-N 0.000 claims 1
- FCRGETOHSQVXGE-UHFFFAOYSA-N 5-imidazol-1-yl-2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol Chemical compound CC(C)NC1CCN(C1)c1ncc(nn1)-c1ccc(cc1O)-n1ccnc1 FCRGETOHSQVXGE-UHFFFAOYSA-N 0.000 claims 1
- YBMNUWYGLDOSFR-UHFFFAOYSA-N 5-imidazol-1-yl-2-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenol hydrochloride Chemical compound Cl.N1(C=NC=C1)C=1C=CC(=C(C1)O)C1=CN=C(N=N1)N1CC(CC1)NC(C)C YBMNUWYGLDOSFR-UHFFFAOYSA-N 0.000 claims 1
- LKKKWEGOGLXKSV-UHFFFAOYSA-N 5-imidazol-1-yl-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound N1(C=NC=C1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C LKKKWEGOGLXKSV-UHFFFAOYSA-N 0.000 claims 1
- ZEOAFUFWAUTHGR-UHFFFAOYSA-N 5-pyridazin-4-yl-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CC1(C)CC(CC(C)(C)N1)NC1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CN=NC=C1 ZEOAFUFWAUTHGR-UHFFFAOYSA-N 0.000 claims 1
- DKBHVEOYQRCKKE-UHFFFAOYSA-N 5-pyrimidin-2-yl-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenol Chemical compound CC1(C)CC(CC(C)(C)N1)NC1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=NC=CC=N1 DKBHVEOYQRCKKE-UHFFFAOYSA-N 0.000 claims 1
- WMNVRCQDPGGRCW-UHFFFAOYSA-N 6-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-2-fluoro-3-(1H-pyrazol-4-yl)phenol Chemical compound C(C)(C)(C)NC1CN(CC1)C=1N=NC(=CN=1)C1=CC=C(C(=C1O)F)C=1C=NNC=1 WMNVRCQDPGGRCW-UHFFFAOYSA-N 0.000 claims 1
- MNNKDERNWFSIFT-UHFFFAOYSA-N 6-[3-[3-(tert-butylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-2-fluoro-3-(1H-pyrazol-4-yl)phenol dihydrochloride Chemical compound Cl.Cl.CC(C)(C)NC1CCN(C1)c1ncc(nn1)-c1ccc(-c2cn[nH]c2)c(F)c1O MNNKDERNWFSIFT-UHFFFAOYSA-N 0.000 claims 1
- MPAGDCJUWXSDJA-UHFFFAOYSA-N 6-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]quinolin-7-ol Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C2N=CC=CC2=C1 MPAGDCJUWXSDJA-UHFFFAOYSA-N 0.000 claims 1
- PVUJUSUQGPYTRV-UHFFFAOYSA-N 6-[3-hydroxy-4-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenyl]-3-methylpyrimidin-4-one Chemical compound OC=1C=C(C=CC=1C1=CN=C(N=N1)N1CC(CC1)NC(C)C)C1=CC(N(C=N1)C)=O PVUJUSUQGPYTRV-UHFFFAOYSA-N 0.000 claims 1
- MPRIBVKAGBMVLE-UHFFFAOYSA-N 6-[3-hydroxy-4-[3-[3-(propan-2-ylamino)pyrrolidin-1-yl]-1,2,4-triazin-6-yl]phenyl]-3-methylpyrimidin-4-one hydrochloride Chemical compound Cl.OC=1C=C(C=CC1C1=CN=C(N=N1)N1CC(CC1)NC(C)C)C1=CC(N(C=N1)C)=O MPRIBVKAGBMVLE-UHFFFAOYSA-N 0.000 claims 1
- YQRVFVZBYSYUHM-UHFFFAOYSA-N 6-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]-3-methylpyrimidin-4-one Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(O)C=C(C=C1)C1=CC(=O)N(C)C=N1 YQRVFVZBYSYUHM-UHFFFAOYSA-N 0.000 claims 1
- KOWITKPLCGTEEL-UHFFFAOYSA-N 6-[3-hydroxy-4-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl]-3-methylpyrimidin-4-one dihydrochloride Chemical compound Cl.Cl.OC=1C=C(C=CC1C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C)C1=CC(N(C=N1)C)=O KOWITKPLCGTEEL-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- TWAQQEOIIQZKOT-VPYROQPTSA-N C(N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C)([2H])([2H])[2H] Chemical compound C(N1N=CC(=C1)C=1C=CC(=C(C=1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C)([2H])([2H])[2H] TWAQQEOIIQZKOT-VPYROQPTSA-N 0.000 claims 1
- USFVVTKYTOQATQ-OWKBQAHQSA-N Cl.C(N1N=CC(=C1)C=1C=CC(=C(C1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C)([2H])([2H])[2H] Chemical compound Cl.C(N1N=CC(=C1)C=1C=CC(=C(C1)O)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C)([2H])([2H])[2H] USFVVTKYTOQATQ-OWKBQAHQSA-N 0.000 claims 1
- YISQCEKJTWVFTL-YLSPSJLGSA-N Cl.Cl.C(N1N=CC(=C1)C=1C=CC(=C(C1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C)([2H])([2H])[2H] Chemical compound Cl.Cl.C(N1N=CC(=C1)C=1C=CC(=C(C1)O)C1=CN=C(N=N1)N(C1CC(NC(C1)(C)C)(C)C)C)([2H])([2H])[2H] YISQCEKJTWVFTL-YLSPSJLGSA-N 0.000 claims 1
- SISBKYXCVOUUTN-ZGNJCNNKSA-N F[C@@H]1C(NC(C[C@@H]1NC=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NN(C=1)C([2H])([2H])[2H])O)(C)C)(C)C Chemical compound F[C@@H]1C(NC(C[C@@H]1NC=1N=NC(=CN=1)C1=C(C=C(C=C1)C=1C=NN(C=1)C([2H])([2H])[2H])O)(C)C)(C)C SISBKYXCVOUUTN-ZGNJCNNKSA-N 0.000 claims 1
- VBTRYICOGSPHFT-UHFFFAOYSA-N N-methyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,2,4-triazin-3-amine Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=CN=N1 VBTRYICOGSPHFT-UHFFFAOYSA-N 0.000 claims 1
- VSYMKJJFDYXAMR-UHFFFAOYSA-N [2-[3-[3-[(cyclopropylamino)methyl]pyrrolidin-1-yl]-1,2,4-triazin-6-yl]-5-(1H-pyrazol-4-yl)phenyl] formate Chemical compound O=COC1=C(C=CC(=C1)C1=CNN=C1)C1=CN=C(N=N1)N1CCC(CNC2CC2)C1 VSYMKJJFDYXAMR-UHFFFAOYSA-N 0.000 claims 1
- LCYKHNZTXQPBMP-UHFFFAOYSA-N [2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyridazin-3-ylphenyl] formate Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(OC=O)C=C(C=C1)C1=CC=CN=N1 LCYKHNZTXQPBMP-UHFFFAOYSA-N 0.000 claims 1
- JDPITFVOCSCWTM-UHFFFAOYSA-N [2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyridin-2-ylphenyl] formate Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(OC=O)C=C(C=C1)C1=NC=CC=C1 JDPITFVOCSCWTM-UHFFFAOYSA-N 0.000 claims 1
- NPJBINVWUGANOE-UHFFFAOYSA-N [2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyrimidin-4-ylphenyl] formate Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(OC=O)C=C(C=C1)C1=CC=NC=N1 NPJBINVWUGANOE-UHFFFAOYSA-N 0.000 claims 1
- ZGQJMPPAUYNUTE-UHFFFAOYSA-N [2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]-5-pyrimidin-5-ylphenyl] formate Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(OC=O)C=C(C=C1)C1=CN=CN=C1 ZGQJMPPAUYNUTE-UHFFFAOYSA-N 0.000 claims 1
- DOTXQIMNCLZKHS-UHFFFAOYSA-N [5-(1-methylbenzimidazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl] formate Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(OC=O)C=C(C=C1)C1=CC=C2N(C)C=NC2=C1 DOTXQIMNCLZKHS-UHFFFAOYSA-N 0.000 claims 1
- LVOPEXUSJAJMDK-UHFFFAOYSA-N [5-(1-methylpyrazol-3-yl)-2-[3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl] formate Chemical compound C(=O)OC1=C(C=CC(=C1)C1=NN(C=C1)C)C1=CN=C(N=N1)NC1CC(NC(C1)(C)C)(C)C LVOPEXUSJAJMDK-UHFFFAOYSA-N 0.000 claims 1
- BCDOROZRDLASMX-UHFFFAOYSA-N [5-(5-methyl-1H-pyrazol-4-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl] formate Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(OC=O)C=C(C=C1)C1=CNN=C1C BCDOROZRDLASMX-UHFFFAOYSA-N 0.000 claims 1
- ZAMICXPNMRTSIV-UHFFFAOYSA-N [5-(6,7-difluoro-1-methylbenzimidazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl] formate Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(OC=O)C=C(C=C1)C1=C(F)C(F)=C2N(C)C=NC2=C1 ZAMICXPNMRTSIV-UHFFFAOYSA-N 0.000 claims 1
- FHJHUSYNOFDPDJ-UHFFFAOYSA-N [5-(6,7-difluoro-3H-benzimidazol-5-yl)-2-[3-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,2,4-triazin-6-yl]phenyl] formate Chemical compound CN(C1CC(C)(C)NC(C)(C)C1)C1=NC=C(N=N1)C1=C(OC=O)C=C(C=C1)C1=C(F)C(F)=C2NC=NC2=C1 FHJHUSYNOFDPDJ-UHFFFAOYSA-N 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 1
- 125000005241 heteroarylamino group Chemical group 0.000 claims 1
- XVQUOJBERHHONY-UHFFFAOYSA-N isometheptene Chemical compound CNC(C)CCC=C(C)C XVQUOJBERHHONY-UHFFFAOYSA-N 0.000 claims 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- PUBSMDUBHLYMIX-UHFFFAOYSA-N phenol;dihydrochloride Chemical compound Cl.Cl.OC1=CC=CC=C1 PUBSMDUBHLYMIX-UHFFFAOYSA-N 0.000 claims 1
- DNRXKUPYJHTZJE-UHFFFAOYSA-N phenol;hydrobromide Chemical compound Br.OC1=CC=CC=C1 DNRXKUPYJHTZJE-UHFFFAOYSA-N 0.000 claims 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 1
- 239000011877 solvent mixture Substances 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 150000003254 radicals Chemical class 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 4
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 3
- 125000005917 3-methylpentyl group Chemical group 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 1
- 150000005840 aryl radicals Chemical group 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004431 deuterium atom Chemical group 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862648699P | 2018-03-27 | 2018-03-27 | |
US62/648,699 | 2018-03-27 | ||
PCT/US2019/024278 WO2019191229A1 (en) | 2018-03-27 | 2019-03-27 | Compounds for treating huntington's disease |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2021519291A JP2021519291A (ja) | 2021-08-10 |
JPWO2019191229A5 true JPWO2019191229A5 (pt-PT) | 2022-03-30 |
JP7399869B2 JP7399869B2 (ja) | 2023-12-18 |
Family
ID=68060393
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020552026A Active JP7399870B2 (ja) | 2018-03-27 | 2019-03-26 | ハンチントン病を処置するための化合物 |
JP2020551538A Active JP7399869B2 (ja) | 2018-03-27 | 2019-03-27 | ハンチントン病を処置するための化合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020552026A Active JP7399870B2 (ja) | 2018-03-27 | 2019-03-26 | ハンチントン病を処置するための化合物 |
Country Status (13)
Country | Link |
---|---|
US (3) | US12103926B2 (pt-PT) |
EP (1) | EP3773552A4 (pt-PT) |
JP (2) | JP7399870B2 (pt-PT) |
KR (2) | KR20210005559A (pt-PT) |
CN (2) | CN112135815A (pt-PT) |
AU (2) | AU2019243048A1 (pt-PT) |
BR (2) | BR112020019373A2 (pt-PT) |
CA (2) | CA3094703A1 (pt-PT) |
EA (2) | EA202092001A1 (pt-PT) |
IL (2) | IL277497A (pt-PT) |
MX (2) | MX2020009957A (pt-PT) |
SG (2) | SG11202009212WA (pt-PT) |
WO (2) | WO2019191092A1 (pt-PT) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2879995T3 (es) | 2015-12-10 | 2021-11-23 | Ptc Therapeutics Inc | Métodos para el tratamiento de la enfermedad de Huntington |
WO2018226622A1 (en) | 2017-06-05 | 2018-12-13 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
CA3067592A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
EP3644996B1 (en) | 2017-06-28 | 2023-07-26 | PTC Therapeutics, Inc. | Methods for treating huntington's disease |
WO2019028440A1 (en) | 2017-08-04 | 2019-02-07 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATING SPLICING |
IL275490B2 (en) | 2017-12-22 | 2024-05-01 | Ravenna Pharmaceuticals Inc | Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors |
JP7399870B2 (ja) | 2018-03-27 | 2023-12-18 | ピーティーシー セラピューティクス, インコーポレイテッド | ハンチントン病を処置するための化合物 |
US11685746B2 (en) | 2018-06-27 | 2023-06-27 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating Huntington's disease |
WO2020005873A1 (en) * | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heterocyclic and heteroaryl compounds for treating huntington's disease |
JP7212781B2 (ja) | 2018-12-19 | 2023-01-25 | ディスアーム セラピューティクス, インコーポレイテッド | 神経保護剤と組み合わせたsarm1の阻害剤 |
KR20210135240A (ko) * | 2019-02-05 | 2021-11-12 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
JP2022521467A (ja) | 2019-02-05 | 2022-04-08 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
JP2022519323A (ja) | 2019-02-06 | 2022-03-22 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
US11129829B2 (en) | 2019-06-17 | 2021-09-28 | Skyhawk Therapeutics, Inc. | Methods for modulating splicing |
TW202112767A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物 |
US20240216369A1 (en) | 2019-11-01 | 2024-07-04 | Novartis Ag | The use of a splicing modulator for a treatment slowing progression of huntington's disease |
JP2023522177A (ja) | 2020-04-09 | 2023-05-29 | ピーティーシー セラピューティクス, インコーポレイテッド | ハンチントン病を処置するための化合物 |
TW202208358A (zh) | 2020-05-13 | 2022-03-01 | 美商Chdi基金會股份有限公司 | 用於治療亨汀頓舞蹈症之htt調節劑 |
TW202216671A (zh) * | 2020-06-25 | 2022-05-01 | 瑞士商諾華公司 | 1,4—二取代的嗒𠯤化合物之製造方法 |
WO2022031998A2 (en) * | 2020-08-05 | 2022-02-10 | Skyhawk Therapeutics, Inc. | Process for the preparation of intermediates useful in the preparation of compounds that modulate splicing |
MX2023001558A (es) * | 2020-08-05 | 2023-04-26 | Skyhawk Therapeutics Inc | Composiciones para modular el corte y empalme. |
WO2022032007A2 (en) * | 2020-08-05 | 2022-02-10 | Skyhawk Therapeutics, Inc. | Process for the preparation of intermediates useful in the preparation of compounds that modulate splicing |
TW202304446A (zh) | 2021-03-29 | 2023-02-01 | 瑞士商諾華公司 | 剪接調節子用於減慢杭丁頓氏舞蹈症進展的治療之用途 |
CA3218212A1 (en) | 2021-04-28 | 2022-11-03 | Astellas Pharma Inc. | Substituted triazine compound |
WO2023028536A1 (en) * | 2021-08-25 | 2023-03-02 | Ptc Therapeutics, Inc. | 1,2,4-triazine derivatives useful as inhibitors of nlrp3 |
WO2023034836A1 (en) * | 2021-08-30 | 2023-03-09 | Remix Therapeutics Inc. | Compounds and methods for modulating splicing |
CN116063307A (zh) * | 2021-10-29 | 2023-05-05 | 中国药科大学 | Shp2与cdk4/6双靶点抑制化合物合成及其制备方法与应用 |
AU2023205375A1 (en) * | 2022-01-07 | 2024-07-18 | Transthera Sciences (Nanjing) , Inc. | Nlrp3 inflammasome inhibitor and uses thereof |
WO2024017924A1 (en) * | 2022-07-21 | 2024-01-25 | F. Hoffmann-La Roche Ag | Nlrp3 inhibitors |
WO2024097598A1 (en) * | 2022-11-02 | 2024-05-10 | Merck Sharp & Dohme Llc | Triazines useful as inhibitors of nod-like receptor protein 3 |
WO2024193541A1 (en) * | 2023-03-20 | 2024-09-26 | Insilico Medicine Ip Limited | Nlrp3 inflammasome inhibitors and uses thereof |
Family Cites Families (209)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL297170A (pt-PT) | 1963-04-04 | 1900-01-01 | ||
US3558618A (en) | 1968-04-01 | 1971-01-26 | Dow Chemical Co | Novel 4h-pyrazino(1,2-a)pyrimidine-4-ones |
GB1383409A (en) | 1972-09-09 | 1974-02-12 | Pfizer Ltd | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
US4122274A (en) | 1977-05-25 | 1978-10-24 | Bristol-Myers Company | 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones |
US4342870A (en) | 1980-03-28 | 1982-08-03 | Janssen Pharmaceutica N.V. | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
JPS56150091A (en) | 1980-03-28 | 1981-11-20 | Janssen Pharmaceutica Nv | 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture |
FR2567518B1 (fr) | 1984-07-11 | 1987-11-13 | Sanofi Sa | Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent |
US5089633A (en) | 1987-04-28 | 1992-02-18 | Georgia Tech Research Corporation | Substituted isocoumarins |
US4902695A (en) * | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
US5599816A (en) | 1990-05-02 | 1997-02-04 | Abbott Laboratories | Quinolizinone type compounds |
EP0640083A1 (en) | 1992-05-13 | 1995-03-01 | E.I. Du Pont De Nemours And Company | Substituted pyrido 1,2-a]pyrimidinone derivatives as fungicides |
CN1123038A (zh) | 1993-05-11 | 1996-05-22 | 北卡罗来纳大学查珀尔希尔分校 | 阻止异常剪接的反义寡核苷酸及其使用方法 |
EP0871628A1 (en) | 1995-06-06 | 1998-10-21 | Abbott Laboratories | Quinolizinone type compounds |
US5916916A (en) | 1996-10-10 | 1999-06-29 | Eli Lilly And Company | 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods |
US5869500A (en) | 1996-12-13 | 1999-02-09 | Hoffmann-La Roche Inc. | Pyridone compounds useful in treating Alzheimer's disease |
CA2269561C (en) | 1998-04-22 | 2007-06-05 | Dainippon Ink And Chemicals, Inc. | Naphthalene derivative and liquid crystal composition comprising the same |
WO2000017197A1 (en) | 1998-09-21 | 2000-03-30 | Biochem Pharma Inc. | Quinolizinones as integrin inhibitors |
US6172216B1 (en) | 1998-10-07 | 2001-01-09 | Isis Pharmaceuticals Inc. | Antisense modulation of BCL-X expression |
US6214986B1 (en) | 1998-10-07 | 2001-04-10 | Isis Pharmaceuticals, Inc. | Antisense modulation of bcl-x expression |
US6210892B1 (en) | 1998-10-07 | 2001-04-03 | Isis Pharmaceuticals, Inc. | Alteration of cellular behavior by antisense modulation of mRNA processing |
EP1227084B1 (en) | 1999-10-28 | 2005-12-14 | Trine Pharmaceuticals, Inc. | Drug discharge pump inhibitors |
CA2398163C (en) | 2000-01-24 | 2011-02-22 | Kinacia Pty Ltd. | Therapeutic morpholino-substituted compounds |
US20050054836A1 (en) | 2000-11-09 | 2005-03-10 | Cold Spring Harbor Laboratory | Chimeric molecules to modulate gene expression |
US6774134B2 (en) | 2000-12-20 | 2004-08-10 | Bristol-Myers Squibb Company | Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
ATE326462T1 (de) | 2000-12-21 | 2006-06-15 | Vertex Pharma | Pyrazolverbindungen als protein-kinase- inhibitoren |
CA2445697A1 (en) | 2001-04-26 | 2002-11-07 | Daiichi Pharmaceutical Co., Ltd. | Drug efflux pump inhibitor |
EP2198867A1 (en) | 2001-12-07 | 2010-06-23 | Vertex Pharmaceuticals, Inc. | Pyrimidine-based compounds useful as GSK-3 inhibitors |
GB0205281D0 (en) | 2002-03-06 | 2002-04-17 | Novartis Ag | Organic compounds |
ATE548354T1 (de) | 2002-07-24 | 2012-03-15 | Ptc Therapeutics Inc | Ureido-substituierte benzoesäureverbindungen und ihre verwendung für die nonsense-suppression und behandlung von erkrankungen |
WO2004019002A2 (en) | 2002-08-23 | 2004-03-04 | The Board Of Trustees Of The Leland Stanford Junior University | Fluorescent glycosides and methods for their use |
DK1551835T3 (da) | 2002-09-30 | 2007-06-04 | Neurosearch As | Hidtil ukendte 1,4-diazabicycloalkanderivater, deres fremstilling og anvendelse |
PL376751A1 (pl) | 2002-11-12 | 2006-01-09 | Abbott Laboratories | Bicykliczne podstawione aminy jako ligandy receptora histaminowego-3 |
US20070078144A1 (en) | 2003-01-29 | 2007-04-05 | Stockwell Brent R | Agents for treating neurodegenerative diseases |
US20040224952A1 (en) | 2003-05-07 | 2004-11-11 | Cowart Marlon D. | Fused bicyclic-substituted amines as histamine-3 receptor ligands |
EP1636225B1 (en) | 2003-06-20 | 2010-02-24 | Novartis Vaccines and Diagnostics, Inc. | Pyridino 1,2-a pyrimidin-4-one compounds as anticancer agents |
GB0315494D0 (en) | 2003-07-02 | 2003-08-06 | Biofocus Plc | Compounds which bind to the active site of protein kinase enzymes |
AU2004261667A1 (en) | 2003-08-01 | 2005-02-10 | Genelabs Technologies, Inc. | Bicyclic imidazol derivatives against Flaviviridae |
US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
US20050074801A1 (en) | 2003-09-09 | 2005-04-07 | Monia Brett P. | Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
US20050245531A1 (en) | 2003-12-22 | 2005-11-03 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
US7309699B2 (en) | 2003-12-22 | 2007-12-18 | Abbott Laboratories | 3-Quinuclidinyl amino-substituted biaryl derivatives |
US7655657B2 (en) | 2003-12-22 | 2010-02-02 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
US20050137203A1 (en) | 2003-12-22 | 2005-06-23 | Jianguo Ji | 3-quinuclidinyl amino-substituted biaryl derivatives |
RU2422444C2 (ru) | 2003-12-24 | 2011-06-27 | Байота Сайентифик Менеджмент Пти Лтд | Полициклические средства для лечения респираторно-синцитиальных вирусных инфекций |
SE0400184D0 (sv) | 2004-01-30 | 2004-01-30 | Fyrkloevern Scandinavia Ab | New therapeutical use |
TW200536830A (en) | 2004-02-06 | 2005-11-16 | Chugai Pharmaceutical Co Ltd | 1-(2H)-isoquinolone derivative |
CA2557852A1 (en) | 2004-04-08 | 2005-10-27 | Neurogen Corporation | Substituted cinnolin-4-ylamines |
ZA200609267B (en) | 2004-04-08 | 2009-02-25 | Targegen Inc | Benzotriazine inhibitors of kinases |
MXPA06012829A (es) | 2004-05-04 | 2007-01-26 | Warner Lambert Co | Pirido[2,3-d]pirimidin-7-onas sustituidas con pirrolilo y derivados de las mismas como agentes terapeuticos. |
US7399767B2 (en) | 2005-01-21 | 2008-07-15 | Ortho-Mcneil Pharmaceutical, Inc. | Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
US7879992B2 (en) | 2005-01-31 | 2011-02-01 | Isis Pharmaceuticals, Inc. | Modification of MyD88 splicing using modified oligonucleotides |
GB0501999D0 (en) | 2005-02-01 | 2005-03-09 | Sentinel Oncology Ltd | Pharmaceutical compounds |
JP2006219453A (ja) | 2005-02-14 | 2006-08-24 | Tokyo Univ Of Pharmacy & Life Science | キノリン環を母核とする金属識別型二波長性蛍光分子 |
US7563601B1 (en) | 2005-06-01 | 2009-07-21 | City Of Hope | Artificial riboswitch for controlling pre-mRNA splicing |
WO2006138418A2 (en) | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
EP2233470B1 (en) | 2005-07-04 | 2011-12-07 | High Point Pharmaceuticals, LLC | Histamine H3 receptor antagonists |
US7473784B2 (en) | 2005-08-01 | 2009-01-06 | Bristol-Myers Squibb Company | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
US7576110B2 (en) | 2005-09-22 | 2009-08-18 | Abbott Laboratories | Benzothiazole cyclobutyl amine derivatives |
WO2007047913A2 (en) | 2005-10-20 | 2007-04-26 | Isis Pharmaceuticals, Inc | Compositions and methods for modulation of lmna expression |
WO2007056580A2 (en) | 2005-11-08 | 2007-05-18 | Pharmadyn, Inc. | Methods and compositions for treating diseases associated with pathogenic proteins |
US20070105807A1 (en) | 2005-11-10 | 2007-05-10 | Sazani Peter L | Splice switch oligomers for TNF superfamily receptors and their use in treatment of disease |
JP2009518357A (ja) | 2005-12-06 | 2009-05-07 | ノイロサーチ アクティーゼルスカブ | 新規なジアザ二環式アリール誘導体及びそれらの医学的使用 |
EP1968968A1 (en) | 2005-12-21 | 2008-09-17 | PainCeptor Pharma Corp. | Compositions and methods for modulating gated ion channels |
PL2161038T3 (pl) | 2006-01-26 | 2014-06-30 | Ionis Pharmaceuticals Inc | Kompozycje i ich zastosowanie ukierunkowane na huntingtynę |
AU2007211082B2 (en) | 2006-01-27 | 2012-09-27 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for the use in modulation of microRNAs |
AR059339A1 (es) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
US8110681B2 (en) | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
CN101410385B (zh) | 2006-03-28 | 2011-08-24 | 高点制药有限责任公司 | 具有组胺h3受体活性的苯并噻唑类 |
WO2007130383A2 (en) | 2006-04-28 | 2007-11-15 | Northwestern University | Compositions and treatments using pyridazine compounds and secretases |
US20080247964A1 (en) | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
WO2007133756A2 (en) | 2006-05-15 | 2007-11-22 | Neurogen Corporation | Crf1 receptor ligands comprising heteroaryl fused bicycles |
US7910578B2 (en) | 2006-05-23 | 2011-03-22 | Neurosearch A/S | 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use |
ATE469144T1 (de) | 2006-07-20 | 2010-06-15 | Amgen Inc | Substituierte pyridonverbindungen und anwendungsverfahren |
US8337941B2 (en) | 2006-07-27 | 2012-12-25 | The Trustees Of Columbia University In The City Of New York | Fluorescent substrates for monoamine transporters as optical false neurotransmitters |
PT2066653E (pt) | 2006-08-03 | 2012-10-22 | Rottapharm Spa | Derivados de 6-1h-imidazo-quinazolina e quinolinas, novos potentes analgésicos e agentes anti-inflamatórios |
WO2008020302A2 (en) | 2006-08-17 | 2008-02-21 | Pfizer Products Inc. | Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors |
US20100029685A1 (en) | 2006-10-25 | 2010-02-04 | Neurosearch A/S | Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
US8314119B2 (en) | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
EP2269992A1 (en) | 2006-12-22 | 2011-01-05 | Avexa Limited | Bicyclic pyrimidinones for the treatment of viral infections |
US20080171792A1 (en) | 2006-12-28 | 2008-07-17 | Jobdevairakkam Christopher New | Use of highly concentrated formulations of 4-phenylbutyrate for treatment of certain disorders |
FR2914188B1 (fr) | 2007-03-28 | 2012-06-22 | Trophos | Nouvelle composition a base d'oxime de cholest-4-en-3-one |
EP2014656A3 (en) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
US20100267712A1 (en) | 2007-09-27 | 2010-10-21 | The United States of America, as represented by the Secretary, Department of Health and | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
DK2193133T3 (en) | 2007-09-27 | 2015-10-05 | Fundacion Ct Nac Investigaciones Oncologicas Carlos Iii | IMIDAZOLOTHIADIAZOLES USED AS PROTEINKINASE INHIBITORS |
US8153813B2 (en) | 2007-12-20 | 2012-04-10 | Abbott Laboratories | Benzothiazole and benzooxazole derivatives and methods of use |
WO2009114874A2 (en) | 2008-03-14 | 2009-09-17 | Intellikine, Inc. | Benzothiazole kinase inhibitors and methods of use |
US20090258907A1 (en) | 2008-04-09 | 2009-10-15 | Abbott Laboratories | Compounds useful as inhibitors of rock kinases |
WO2009131958A2 (en) | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising triazine derivatives |
US8633019B2 (en) | 2008-05-27 | 2014-01-21 | Ptc Therapeutics, Inc. | Methods for treating spinal muscular atrophy |
WO2009152868A1 (en) | 2008-06-20 | 2009-12-23 | Rottapharm S.P.A. | 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands |
EP2138493A1 (en) | 2008-06-26 | 2009-12-30 | Sanofi-Aventis | Substituted pyrimidone derivatives |
MX2011000149A (es) | 2008-07-02 | 2011-02-24 | Avexa Ltd | Compuestos que tienen propiedades antivirales. |
WO2010019236A1 (en) | 2008-08-13 | 2010-02-18 | Ptc Therapeutics, Inc | Methods for treating spinal muscular atrophy |
WO2010024903A1 (en) | 2008-08-29 | 2010-03-04 | Yangbo Feng | BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS |
US20110224187A1 (en) | 2008-10-16 | 2011-09-15 | Anandan Palani | Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
GB2465405A (en) | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
US8283360B2 (en) | 2008-12-19 | 2012-10-09 | Merck Sharp & Dohme Corp. | Bicyclic heterocyclic derivatives and methods of use thereof |
KR20110132564A (ko) | 2009-02-11 | 2011-12-08 | 선오비온 파마슈티컬스 인코포레이티드 | 히스타민 h3 역 작용제 및 길항제, 및 이의 사용 방법 |
FR2945289A1 (fr) | 2009-05-11 | 2010-11-12 | Sanofi Aventis | Derives de 2-cycloamino-5-(pyridin-4-yl)imidazo°2,1-b! °1,3,4!thiadiazole, leur preparation et leur application en therapeutique |
WO2010144909A1 (en) | 2009-06-12 | 2010-12-16 | Novartis Ag | Fused heterocyclic compounds and their uses |
MX2011014019A (es) | 2009-06-19 | 2012-02-22 | Abbott Lab | Derivados de diazahomoadamantano y sus metodos de uso. |
CN102625809B (zh) | 2009-09-11 | 2015-06-24 | Isis制药公司 | 亨廷顿表达的调节 |
WO2011050245A1 (en) | 2009-10-23 | 2011-04-28 | Yangbo Feng | Bicyclic heteroaryls as kinase inhibitors |
WO2011057204A2 (en) | 2009-11-06 | 2011-05-12 | The Johns Hopkins University | Lrrk2-mediated neuronal toxicity |
US8754220B2 (en) | 2009-11-20 | 2014-06-17 | Merck Sharp & Dohme Corp. | Quinolizidinone carboxamide M1 receptor positive allosteric modulators |
JP2013517233A (ja) | 2010-01-13 | 2013-05-16 | インスティチュート・パスツール・コリア | 抗感染ピリド(1,2−a)ピリミジン |
JP6006120B2 (ja) | 2010-02-08 | 2016-10-12 | アイオーニス ファーマシューティカルズ, インコーポレーテッドIonis Pharmaceuticals,Inc. | 対立遺伝子多様体の選択的低減 |
JP2013518603A (ja) | 2010-02-08 | 2013-05-23 | アイシス ファーマシューティカルズ, インコーポレーテッド | 反復伸張に関連する疾患または病態の治療に有用な方法および組成物 |
JP6018506B2 (ja) | 2010-02-08 | 2016-11-02 | アイオーニス ファーマシューティカルズ, インコーポレーテッドIonis Pharmaceuticals,Inc. | 対立遺伝子多様体の選択的低減 |
US8940716B2 (en) | 2010-05-06 | 2015-01-27 | Bristol-Myers Squibb Company | Bicyclic heteroaryl compounds as GPR119 modulators |
EP2575866A4 (en) | 2010-05-24 | 2013-10-16 | Presidio Pharmaceuticals Inc | HCV NS5A INHIBITORS |
EP2595664B1 (en) | 2010-07-19 | 2018-10-17 | Ionis Pharmaceuticals, Inc. | Modulation of nuclear-retained rna |
WO2012019106A2 (en) | 2010-08-06 | 2012-02-09 | Board Of Regents Of The University Of Nebraska | Positive and negative modulators of nmda receptors |
WO2012075393A2 (en) | 2010-12-02 | 2012-06-07 | President And Fellows Of Harvard College | Activators of proteasomal degradation and uses thereof |
CN102617548A (zh) | 2011-01-31 | 2012-08-01 | 北京赛林泰医药技术有限公司 | 作为gpr受体激动剂的双环杂芳基化合物及其组合物和应用 |
WO2012104823A2 (en) | 2011-02-04 | 2012-08-09 | Novartis Ag | Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases |
EA026745B8 (ru) | 2011-02-07 | 2022-01-31 | Байоджен Ма Инк. | Модуляторы s1p |
EP2673361B1 (en) | 2011-02-08 | 2016-04-13 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds comprising bicyclic nucleotides and uses thereof |
US8703763B2 (en) | 2011-03-02 | 2014-04-22 | Hoffmann-La Roche Inc. | Bridged piperidine derivatives |
US9447075B2 (en) | 2011-08-02 | 2016-09-20 | The Brigham And Women's Hospital, Inc. | Pyridazine derivatives as EAAT2 activators |
US8871756B2 (en) | 2011-08-11 | 2014-10-28 | Hoffmann-La Roche Inc. | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease |
DK2742135T4 (da) | 2011-08-11 | 2020-07-13 | Ionis Pharmaceuticals Inc | Bindingsmodificerede gapped oligomeriske forbindelser og anvendelser deraf |
EP2560008B1 (en) | 2011-08-18 | 2016-11-30 | Korea Institute of Science and Technology | Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same |
US9976138B2 (en) | 2011-08-29 | 2018-05-22 | Ionis Pharmaceuticals, Inc. | Methods and compounds useful in conditions related to repeat expansion |
WO2013059606A1 (en) | 2011-10-21 | 2013-04-25 | Tufts Medical Center, Inc. | Compounds and methods for the treatment of muscular disease, and related screening methods |
GB201119538D0 (en) | 2011-11-10 | 2011-12-21 | Viral Ltd | Pharmaceutical compounds |
AU2012345557A1 (en) | 2011-11-28 | 2014-06-26 | Novartis Ag | Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
WO2013101974A1 (en) | 2011-12-30 | 2013-07-04 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
PL2809322T3 (pl) | 2012-01-26 | 2019-11-29 | Ptc Therapeutics Inc | Związki do leczenia zaniku mięśni pochodzenia rdzeniowego |
WO2013119916A2 (en) | 2012-02-10 | 2013-08-15 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
MX352962B (es) | 2012-03-01 | 2017-12-15 | Ptc Therapeutics Inc | Compuestos para tratar atrofia muscular espinal. |
EP2828247B1 (en) | 2012-03-23 | 2019-01-16 | PTC Therapeutics, Inc. | 4h-chromen-4-one derivatives for treating spinal muscular atrophy |
WO2013151877A1 (en) | 2012-04-03 | 2013-10-10 | Bristol-Myers Squibb Company | Pyrimidinedione carboxamide inhibitors of endothelial lipase |
NZ731797A (en) | 2012-04-24 | 2018-08-31 | Vertex Pharma | Dna-pk inhibitors |
CA2871715A1 (en) | 2012-05-15 | 2013-11-21 | Novartis Ag | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 |
CA2878895A1 (en) | 2012-07-13 | 2014-01-16 | Indiana University Research & Technology Corporation | Compounds for treatment of spinal muscular atrophy |
US8729263B2 (en) | 2012-08-13 | 2014-05-20 | Novartis Ag | 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions |
EP4144845B1 (en) | 2012-10-12 | 2024-04-24 | Ionis Pharmaceuticals, Inc. | Antisense compounds and uses thereof |
WO2014059356A2 (en) | 2012-10-12 | 2014-04-17 | Isis Pharmaceuticals, Inc. | Selective antisense compounds and uses thereof |
US9227976B2 (en) | 2012-10-25 | 2016-01-05 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
PL2911671T3 (pl) | 2012-10-25 | 2018-11-30 | Usher Iii Initiative, Inc. | Pirazolopirydazyny oraz sposoby leczenia zwyrodnieniowych chorób siatkówki i utraty słuchu związanych z zespołem ushera |
JP6255711B2 (ja) | 2012-11-01 | 2018-01-10 | 株式会社リコー | エレクトロクロミック化合物、エレクトロクロミック組成物及び表示素子 |
US9040712B2 (en) | 2013-01-23 | 2015-05-26 | Novartis Ag | Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions |
EP3778618A1 (en) | 2013-02-04 | 2021-02-17 | Ionis Pharmaceuticals, Inc. | Selective antisense compounds and uses thereof |
AU2014224975B2 (en) | 2013-03-05 | 2017-09-14 | Merck Patent Gmbh | Triazolo(4,5-d)pyrimidine derivatives for the treatment of diseases such as cancer |
EP2997028A1 (en) | 2013-05-14 | 2016-03-23 | F.Hoffmann-La Roche Ag | Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection |
MX363456B (es) | 2013-06-25 | 2019-03-25 | Hoffmann La Roche | Compuestos para tratar atrofia muscular espinal. |
CN105636953B (zh) | 2013-07-31 | 2018-01-02 | 诺华股份有限公司 | 1,4‑二取代的哒嗪衍生物及其用于治疗与smn缺乏相关的病症的用途 |
CN105392790B (zh) | 2013-08-19 | 2019-04-19 | 豪夫迈·罗氏有限公司 | 4H-吡啶并[1,2-a]嘧啶-4-酮化合物制备用于预防或治疗癌症的药物的用途 |
WO2015105657A1 (en) | 2013-12-19 | 2015-07-16 | Ptc Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
WO2015095446A1 (en) | 2013-12-19 | 2015-06-25 | Ptc Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
WO2015095449A1 (en) | 2013-12-19 | 2015-06-25 | Ptc Therapeutics, Inc. | Methods for modulating the amount rna transcripts |
CN106068325B (zh) | 2014-01-16 | 2021-07-09 | 波涛生命科学有限公司 | 手性设计 |
CN105899493B (zh) | 2014-01-17 | 2019-03-29 | 诺华股份有限公司 | 用于抑制shp2活性的1-(三嗪-3-基/哒嗪-3-基)-哌(-嗪)啶衍生物及其组合物 |
AR099134A1 (es) | 2014-01-24 | 2016-06-29 | Hoffmann La Roche | Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina |
CA2940621C (en) * | 2014-03-14 | 2022-03-15 | Raqualia Pharma Inc. | Azaspiro derivatives as trpm8 antagonists |
AU2015231239B2 (en) | 2014-03-19 | 2018-11-29 | Amydis, Inc. | Amyloid targeting agents and methods of using the same |
AU2015261046C1 (en) | 2014-05-15 | 2019-07-25 | F. Hoffmann-La Roche Ag | Compounds for treating spinal muscular atrophy |
GB201410693D0 (en) | 2014-06-16 | 2014-07-30 | Univ Southampton | Splicing modulation |
EP3157875A2 (en) | 2014-06-17 | 2017-04-26 | Novozymes A/S | Biological phosphorus removal from wastewater |
EP3160967B1 (en) | 2014-06-25 | 2019-05-08 | F. Hoffmann-La Roche AG | N-(imidazo[1,2-a]pyrazin-6-yl)-benzamide compounds for treating spinal muscular atrophy |
BR112017009010A2 (pt) | 2014-10-31 | 2017-12-26 | Massachusetts Gen Hospital | moduladores potentes de gama-secretase |
GB201419579D0 (en) | 2014-11-03 | 2014-12-17 | Iomet Pharma Ltd | Pharmaceutical compound |
CN107207526A (zh) | 2014-12-02 | 2017-09-26 | 拜耳作物科学股份公司 | 作为害虫防治剂的双环化合物 |
MX2017008500A (es) | 2014-12-24 | 2018-02-01 | Uniqure Ip Bv | Supresión del gen de la huntingtina inducida por la arni. |
PL3244891T3 (pl) | 2015-01-16 | 2022-12-27 | The General Hospital Corporation | Związki poprawiające splicing mRNA |
EP3256126B1 (en) | 2015-02-09 | 2024-03-27 | F. Hoffmann-La Roche AG | Compounds for the treatment of cancer |
GB201502567D0 (en) | 2015-02-16 | 2015-04-01 | Sentinel Oncology Ltd | Pharmaceutical compounds |
CN107635984B (zh) | 2015-03-11 | 2021-04-13 | Fmc公司 | 杂环取代的二环唑杀有害生物剂 |
GB201506933D0 (en) | 2015-04-23 | 2015-06-10 | Sentinel Oncology Ltd | Pharmaceutical compounds |
CN107635999B (zh) | 2015-05-20 | 2020-09-25 | 豪夫迈·罗氏有限公司 | 用于治疗脊髓性肌萎缩的化合物 |
EP4249472A3 (en) | 2015-05-30 | 2023-12-13 | PTC Therapeutics, Inc. | Methods for modulating rna splicing |
MA43072A (fr) | 2015-07-22 | 2018-05-30 | Wave Life Sciences Ltd | Compositions d'oligonucléotides et procédés associés |
WO2017023987A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
WO2017059251A1 (en) | 2015-10-02 | 2017-04-06 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
JP2018533594A (ja) | 2015-11-12 | 2018-11-15 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 筋萎縮性側索硬化症を処置するための化合物 |
WO2017080967A1 (en) | 2015-11-12 | 2017-05-18 | F. Hoffmann-La Roche Ag | Compositions for treating spinal muscular atrophy |
US10383867B2 (en) | 2015-11-28 | 2019-08-20 | Russell Dahl | Quinoline derivatives and their use for treating endoplasmic reticulum stress-related diseases and disorders |
ES2879995T3 (es) | 2015-12-10 | 2021-11-23 | Ptc Therapeutics Inc | Métodos para el tratamiento de la enfermedad de Huntington |
CN108137579B (zh) | 2015-12-10 | 2022-01-07 | 豪夫迈·罗氏有限公司 | 桥连哌啶衍生物 |
CN109071528B (zh) | 2016-03-11 | 2023-02-17 | Ac免疫有限公司 | 用于诊断和治疗的双环化合物 |
US10526345B2 (en) | 2016-04-08 | 2020-01-07 | Mankind Pharma Ltd. | Compounds as GPR119 agonists |
AR108325A1 (es) | 2016-04-27 | 2018-08-08 | Samumed Llc | Isoquinolin-3-il carboxamidas y preparación y uso de las mismas |
MA45270A (fr) | 2016-05-04 | 2017-11-09 | Wave Life Sciences Ltd | Compositions d'oligonucléotides et procédés associés |
AU2017274199B2 (en) | 2016-05-31 | 2021-09-23 | Board Of Regents, The University Of Texas System | Heterocyclic inhibitors of PTPN11 |
US10730868B2 (en) | 2016-07-14 | 2020-08-04 | Bristol-Myers Squibb Company | Bicyclic heteroaryl substituted compounds |
WO2018022473A1 (en) | 2016-07-25 | 2018-02-01 | Wave Life Sciences Ltd. | Phasing |
GB201616627D0 (en) | 2016-09-30 | 2016-11-16 | Mission Therapeutics Limited | Novel compounds |
TWI848901B (zh) | 2016-10-24 | 2024-07-21 | 美商傳達治療有限公司 | Shp2磷酸酶抑制劑及其使用方法 |
EP3606562A4 (en) | 2017-04-03 | 2020-11-11 | Acceleron Pharma Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF SPINAL MUSCLE ATROPHY |
EP3630770B1 (en) | 2017-05-26 | 2024-08-28 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors |
WO2018226622A1 (en) | 2017-06-05 | 2018-12-13 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
EP3644996B1 (en) | 2017-06-28 | 2023-07-26 | PTC Therapeutics, Inc. | Methods for treating huntington's disease |
CA3067592A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
WO2019028440A1 (en) * | 2017-08-04 | 2019-02-07 | Skyhawk Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MODULATING SPLICING |
EP3755699A1 (en) | 2018-02-21 | 2020-12-30 | Relay Therapeutics, Inc. | Shp2 phosphatase inhibitors and methods of use thereof |
IL301106A (en) | 2018-03-21 | 2023-05-01 | Relay Therapeutics Inc | SHP2 phosphatase inhibitors and methods of using them |
US20210069188A1 (en) | 2018-03-21 | 2021-03-11 | Relay Therapeutics, Inc. | Pyrazolo[3,4-b]pyrazine shp2 phosphatase inhibitors and methods of use thereof |
JP7399870B2 (ja) | 2018-03-27 | 2023-12-18 | ピーティーシー セラピューティクス, インコーポレイテッド | ハンチントン病を処置するための化合物 |
MX2020014315A (es) | 2018-06-27 | 2021-05-27 | Ptc Therapeutics Inc | Compuestos de heteroarilo para tratar la enfermedad de huntington. |
WO2020005873A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heterocyclic and heteroaryl compounds for treating huntington's disease |
US11685746B2 (en) | 2018-06-27 | 2023-06-27 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating Huntington's disease |
EP3937942A4 (en) | 2019-03-15 | 2022-11-16 | Skyhawk Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR CORRECTING ABERRANT SPLICING |
JP2022533120A (ja) | 2019-05-13 | 2022-07-21 | ピーティーシー セラピューティクス, インコーポレイテッド | ハンチントン病を処置するための化合物 |
WO2021007378A1 (en) | 2019-07-11 | 2021-01-14 | Ptc Therapeutics, Inc. | Compounds for use in treating huntington's disease |
US20240216369A1 (en) | 2019-11-01 | 2024-07-04 | Novartis Ag | The use of a splicing modulator for a treatment slowing progression of huntington's disease |
JP2023522177A (ja) | 2020-04-09 | 2023-05-29 | ピーティーシー セラピューティクス, インコーポレイテッド | ハンチントン病を処置するための化合物 |
EP4244362A1 (en) | 2020-11-12 | 2023-09-20 | PTC Therapeutics, Inc. | Novel rna transcript |
KR20240054264A (ko) | 2021-07-30 | 2024-04-25 | 피티씨 테라퓨틱스, 인크. | Heteroaryl compounds for treating huntington's disease |
-
2019
- 2019-03-26 JP JP2020552026A patent/JP7399870B2/ja active Active
- 2019-03-26 US US17/040,751 patent/US12103926B2/en active Active
- 2019-03-26 SG SG11202009212WA patent/SG11202009212WA/en unknown
- 2019-03-26 AU AU2019243048A patent/AU2019243048A1/en not_active Abandoned
- 2019-03-26 EA EA202092001A patent/EA202092001A1/ru unknown
- 2019-03-26 CA CA3094703A patent/CA3094703A1/en active Pending
- 2019-03-26 KR KR1020207027340A patent/KR20210005559A/ko not_active Application Discontinuation
- 2019-03-26 MX MX2020009957A patent/MX2020009957A/es unknown
- 2019-03-26 BR BR112020019373-9A patent/BR112020019373A2/pt not_active Application Discontinuation
- 2019-03-26 CN CN201980022422.XA patent/CN112135815A/zh active Pending
- 2019-03-26 WO PCT/US2019/024068 patent/WO2019191092A1/en unknown
- 2019-03-27 BR BR112020019264-3A patent/BR112020019264A2/pt unknown
- 2019-03-27 KR KR1020207027339A patent/KR20210005558A/ko not_active Application Discontinuation
- 2019-03-27 CN CN201980022516.7A patent/CN112203653B/zh active Active
- 2019-03-27 JP JP2020551538A patent/JP7399869B2/ja active Active
- 2019-03-27 EP EP19777730.3A patent/EP3773552A4/en active Pending
- 2019-03-27 EA EA202092003A patent/EA202092003A1/ru unknown
- 2019-03-27 CA CA3094700A patent/CA3094700A1/en active Pending
- 2019-03-27 AU AU2019243943A patent/AU2019243943A1/en not_active Abandoned
- 2019-03-27 SG SG11202009211VA patent/SG11202009211VA/en unknown
- 2019-03-27 MX MX2020009956A patent/MX2020009956A/es unknown
- 2019-03-27 US US17/040,104 patent/US11780839B2/en active Active
- 2019-03-27 WO PCT/US2019/024278 patent/WO2019191229A1/en unknown
-
2020
- 2020-09-22 IL IL277497A patent/IL277497A/en unknown
- 2020-09-22 IL IL277498A patent/IL277498A/en unknown
-
2023
- 2023-06-16 US US18/211,134 patent/US20230331725A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2019191229A5 (pt-PT) | ||
US10934302B1 (en) | SHP2 phosphatase inhibitors and methods of use thereof | |
CN112203653B (zh) | 用于治疗亨廷顿氏病的化合物 | |
AU2019203444B2 (en) | Bicyclic lactams and methods of use thereof | |
JPWO2019191092A5 (pt-PT) | ||
CN114245794B (zh) | 用于治疗亨廷顿氏病的化合物 | |
BR112021001292A2 (pt) | compostos heterobicíclicos para inibir a atividade de shp2 | |
JP2021503004A5 (pt-PT) | ||
CN114728935A (zh) | Shp2抑制剂 | |
WO2020005882A1 (en) | Heteroaryl compounds for treating huntington's disease | |
JPWO2020005877A5 (pt-PT) | ||
JPWO2020005873A5 (pt-PT) | ||
JP2015504057A5 (pt-PT) | ||
IL297044A (en) | Compounds for the treatment of Huntington's disease | |
JPWO2020231977A5 (pt-PT) | ||
US20230159558A1 (en) | Spirotricycle ripk1 inhibitors and methods of uses thereof | |
RU2021111918A (ru) | Модуляторы моноацилглицерин-липазы | |
EA046152B1 (ru) | Соединения для лечения болезни гентингтона | |
KR20160045819A (ko) | 알킨일 알코올 및 이용 방법 |